Structure for determination of item of interest in a sample

Information

  • Patent Grant
  • 6562298
  • Patent Number
    6,562,298
  • Date Filed
    Friday, April 23, 1999
    25 years ago
  • Date Issued
    Tuesday, May 13, 2003
    21 years ago
Abstract
The embodiments disclosed relate to determination of an item of interest in a sample. One embodiment relates to a structure which comprises a process path. The process path comprises a process lane including a process step performance lane where a process step is performed, and a process step avoidance lane where the process step is avoided. A first prime mover is operatively connected with the process path for moving a container holding the sample along the process path. A first pipetting system is operatively associated with the process path for introducing the sample to the container. A second pipetting system is operatively associated with the process path for introducing a reagent to the container. A device is operatively connected with the process path and is selectively engagable with the container for mixing the sample and the reagent in the container. A second prime mover is operatively connected with the process path for selectively positioning the container in a selected one of the process step performance lane and the process step avoidance lane. A reader is operatively connected with the process path for determining the item of interest in the sample based upon a reaction between the sample and the reagent.
Description




BACKGROUND




Embodiments described herein relate generally to methods and structures which determine an item of interest in a sample.




To provide information about a patient's health, a number of tests can be performed on a patient sample, such as the patient's bodily fluids. These bodily fluids may include blood, urine, etc. The tests performed on the patient's bodily fluids can determine an item of interest in the bodily fluids. Based on the determination of the item of interest in the patient's bodily fluids, information about the patient's health status can be obtained.




SUMMARY




One embodiment discussed herein relates to a structure for performing a process for determining an item of interest in a sample. The structure comprises a process path. The process path comprises a process lane including a process step performance lane where a process step is performed, and a process step avoidance lane where the process step is avoided. A first prime mover is operatively connected with the process path for moving a container holding the sample along the process path. A first pipetting system is operatively associated with the process path for introducing the sample to the container. A second pipetting system is operatively associated with the process path for introducing a reagent to the container. A device is operatively connected with the process path and is selectively engagable with the container for mixing the sample and the reagent in the container. A second prime mover is operatively connected with the process path for selectively positioning the container in a selected one of the process step performance lane and the process step avoidance lane. A reader is operatively connected with the process path for determining the item of interest in the sample based upon a reaction between the sample and the reagent.




In another embodiment, the structure comprises a process path. The process path comprises a process lane accepting a container for the sample. The process lane includes a process step performance lane where a process step is performed, and a process step avoidance lane where the process step is avoided.




In an additional embodiment, a structure comprises a process step performance lane accepting a container for the sample where a process step is performed, and a process step avoidance lane accepting the container where the process step is avoided.




Another embodiment provides a structure comprising a cover, a base connected with the cover, a disk rotatably disposed between the cover and the base and a slot disposed on the disk for accepting a container for the sample. The slot has a longitudinal axis and the container is movable along the longitudinal axis.




Yet a further embodiment provides a structure comprising a process lane for accepting a container for holding the sample. The process lane includes a bypass region for selectively automatically performing a process step on the sample in the container.




Other embodiments provide a structure comprising a process lane for accepting a container for holding the sample. The process lane includes an element for providing selective automated performance of a determination of item of interest process step.











BRIEF DESCRIPTION OF DRAWINGS





FIG. 1

is a perspective view of a component of an analyzer;





FIG. 2

shows the component of

FIG. 1

with elements thereof removed for clarity;





FIG. 3

is a perspective view of an element of the component shown in

FIG. 1

;





FIG. 4

is a top view of the component of

FIG. 1

with elements thereof removed for clarity;





FIGS. 5A and 5B

show another element of the component of

FIG. 1

which is connected with the structure shown in

FIG. 2

;





FIG. 6

is an enlarged sectional view of the component of

FIG. 1

with elements removed for clarity;





FIG. 7A

is a perspective view of a container for use with the component of

FIG. 1

;





FIG. 7B

is a perspective view of another container for use with the component of

FIG. 1

;





FIG. 8

is an enlarged sectional view of a portion of the component of

FIG. 1

showing interaction with the container of

FIG. 7B

;





FIG. 9

is an enlarged sectional view, substantially similar to that of

FIG. 8

, of another portion of the component of

FIG. 1

;





FIG. 10

is substantially similar to

FIG. 9

but shows another portion oft the component of

FIG. 1

;





FIG. 11

is substantially similar to

FIG. 10

but shows another portion of the component of

FIG. 1

;





FIG. 12

is a perspective view of an element of the component of

FIG. 1

;





FIG. 13

is an enlarged sectional view of a section of another embodiment of the component shown in

FIG. 1

;





FIG. 14

is a perspective view of an element of the component of

FIG. 1

;





FIG. 15

is a perspective view of an element of the component of

FIG. 1

;





FIG. 16

is a generic view of the component of

FIG. 1

cooperating with other portions of an analyzer;





FIG. 17

is a perspective view of a frame for the structures shown in

FIG. 16

;





FIGS. 18A

,


18


B and


18


C illustrate an element of the component shown in

FIG. 1

;





FIG. 19

is an enlarged sectional view of a section of another embodiment substantially similar to that shown in

FIG. 13

;





FIGS. 20A and 20B

are generic views of other related analyzers having oppositely directed components substantially similar to the component of

FIG. 1

;





FIGS. 21A

,


21


B and


21


C show an embodiment of a high density data carrier which may be used with the component of

FIG. 1

;





FIG. 22

is an isometric view of a container for use with the process path of

FIG. 1

;





FIGS. 23A

,


23


B and


23


C show another container for use with the process path of

FIG. 1

;





FIGS. 24A and 24B

are enlarged sectional views of a portion of the container of

FIGS. 23A

,


23


B and


23


C operatively associated with a support;





FIG. 25

is an isometric view of a seal which may be used with the containers of

FIGS. 22

,


23


A,


23


B and


23


C;





FIG. 26

is an enlarged section of another application of the process path of

FIG. 1

;





FIG. 27

is an enlargement of a portion of

FIG. 27

;





FIG. 28

is a generic view of another related analyzer having a component substantially similar to the component of

FIG. 1

;





FIG. 29

is an illustration of two components of

FIG. 1

joined together;





FIG. 30

is an enlarged view of a portion of

FIG. 29

;





FIGS. 31A

,


31


B and


31


C show another container for use with the process path of

FIG. 1

; and





FIGS. 32A and 32B

illustrate portions of another embodiment of the process path.











DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS




The embodiments described herein relate to methods and structures for determining an item of interest in a sample. The item of interest may be an antibody, an antigen, concentrations of the former or latter or any other desired element of the sample. In an exemplary embodiment, the item of interest is selected from, but are no limited to, antibodies to HCV, antibodies to HIV 1/HIV 2, antibodies to hepatitis B core antigen (HBcAb), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), Hepatitis B Surface Antigen (HBsAg), antibodies to Hepatitis B Surface antigen (HBsAb), alpha-fetoprotein (AFP), Total prostate specific antigen (Total PSA), Free PSA, Thyroid stimulating Hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), beta human chorionic gonadotropin (B-hCG), Free Thyroxine (Free T4), Free triiodothyronine (Free T3), Total T4, Total T3, Progesterone, Testosterone, Estradiol, Prolactin, vitamin B12 (B12), Folate, Glycated Hemoglobin, and Ferritin. The structures and methods may be employed in a number of different configurations.




For the sake of clarity of understanding, the structures and methods will be discussed with respect to their employment in an immunoassay analyzer which performs approximately 200 determinations of items of interest in a sample in an hour. It is to be noted that the structures and methods can be used in other employments, such as analyzers which perform 600, 400, 100, 50, etc. determinations in an hour. A number of analyzers may be joined together or integrated to meet individual needs, such as modifying the number of tests performed in a given time period (throughput), tailoring the items of interest to be determined, etc. For example a number X of analyzers which perform Y determinations in a given hour may be connected such that the connected analyzers perform XY determinations in an hour.




It is to be noted that all such analyzers perform all determinations of items on interest in substantially the same way. For instance, all determination process steps for all items of interest are performed within the same time frame, such as 18 seconds, irrespective of the number or type of determinations to be performed by the given analyzer. These analyzers may include common elements, such as reagents, disposable articles, element, such as fluids and the like, delivery technologies, determination step performance mechanisms, software, etc.




In other applications, the analyzer may be joined, e.g. with a conveyor system and the like, along with supporting hardware and software, such that the analyzer can be used with different analyzers, such as clinical chemistry or hematology analyzers and the like, in the same setting. This conveyor system may move samples among the analyzers such that different determinations can be made with respect to one sample. Also, while operation of the analyzer is described herein with respect to only one analyzer, for the sake of clarity, it is to be remembered that multiple analyzers can operate in the same of in different fashion, either simultaneously or at different times. Furthermore, steps of one method of operation can be combined with steps of another method of operation to arrive at yet more methods of operation.




As illustrated in

FIG. 1

, the analyzer comprises a process path


10


. It is understood that there are other elements (not shown), such as fluid delivery mechanisms, suppliers, and the like, of the analyzer that support operation of the process path


10


. While the process path


10


is illustrated as being substantially circular in configuration, the process path


10


may take other configurations, such as linear, serpentine, etc., as desired.




The process path


10


includes a cover


12


and a base


14


. The base


14


may be attached to a support frame (

FIG. 17

) and the cover


12


is attached to the base


14


. The cover


12


may be a single piece or may comprise multiple, sometimes 6, pieces. Various elements, some of which are described below, of the process path


10


are connected to at least one of the cover


12


and the base


14


. The cover


12


and the base


14


include structures, such as openings and the like, for accommodating some of the elements. In, one embodiment, the base


14


has an inner diameter of about 24.58 inches, an outer diameter of about 30.08 inches and a height of about 1.99 inches. The base


14


may be made of any suitable material, such as a metal, a polymer and the like. In one embodiment, the base


14


is made of anodized aluminum, including a reduced friction coating, such as a PTFE-impregnated anodized coating. In a particular embodiment, the base


14


is made from 6061-T6 aluminum with a MIL-A-63576, Type I finish. The cover


12


may be made of a material which is substantially similar to the material of the base


14


.





FIG. 2

shows the process path


10


with the cover


12


removed from the base


14


. With the cover


12


removed, a disk


16


is visible. The disk


16


is located between the cover


12


and the base


14


and is movable with respect to both the cover


12


and the base


14


.




In some embodiments, the disk


16


may be replaced by a belt


16


′, shown in

FIGS. 32A and 32B

, driven by a wheel


17


. Use of the belt


16


′ provides for orientations other than substantially circular, i.e. serpentine and like, of the process path


10


. The belt


16


′ moves with respect to the cover


12


and the base


14


in substantially the same manner as the disk


16


. In other aspects, construction of the process path


10


is substantially similar irrespective of use of the disk


16


or the belt


16


′.




The disk


16


, illustrated more clearly in

FIG. 3

, has, in one embodiment, an inner radius of about 25.2 inches and an outer radius of about 29.3 inches. The disk


16


may have a thickness of about 0.063 inches. The disk


16


may be formed from any suitable material, such as a polymer and the like. In a particular embodiment, the disk


16


is made from polyvinyl chloride. The disk


16


may be machined, molded or the like. In an exemplary embodiment, the material comprising the disk


16


is chosen with respect to the material of the base


14


to reduce friction between the base


14


and the disk


16


.




A plurality


112


in the illustrated embodiment, of slots


18


are disposed on the disk


16


. As is discussed in greater detail later, the slots


18


cooperate with structures on the base


14


to move containers


15


(

FIGS. 7A and 7B

) along the process path


10


. Each slot


18


has, with respect to the disk


16


in an exemplary embodiment, a radial length of about 1.75 inches and a tangential width of about 0.45 inches with a slot


18


centerline being located at a radius of about 13.614 inches. As is discussed further below, the slot


18


has a longitudinal axis and the container


15


is capable of moving within the slot


18


along the slot's


18


longitudinal axis. To facilitate movement of the container


15


along the longitudinal axis of the slot


18


, the process path


10


may include a configuration, such as a surface, a diverter, a prime mover engagable with the container


15


, and the like. In another embodiment, one end of the slot


18


may include a latitudinally expanded width (

FIG. 13

) to facilitate removal of a container


15


from the disk


16


. In still a further embodiment, the latitudinally expanded width may be located at another region of the slot


18


(FIG.


19


).




The disk


16


is configured to facilitate movement of the disk


16


with respect to the cover


12


and the base


14


. In one embodiment, a plurality of teeth


20


are disposed along an outer diameter surface of the disk


16


. In an exemplary embodiment, the teeth


20


may be about 938 in number with a diametral pitch of about 32, a pressure angle of about 20 degrees and a pitch diameter of about 29.3125 inches.




As shown in

FIG. 6

, the teeth


20


mate with a gear


22


which is driven by a prime mover


24


attached to the base cover


12


by a bracket


26


. In an exemplary embodiment, the gear


22


is made from Estane 58130 natural 92A/50D polyurethane and the motor


24


is a P21 model available from Pacific Scientific of Rockford, Ill. The prime mover


24


, the entire process path


10


and its supporting elements, are connected with and are operated by a suitable controller, such as a computer (not shown) running appropriate routine and the like. In this manner, the disk


16


moves responsive to movement of the gear


22


by the prime mover


24


. In a particular embodiment, the prime mover


24


is a stepper motor.




Referring to

FIG. 4

, the base


14


includes structures to facilitate determination of an item of interest in a sample. The base


14


comprises at least one lane


28


for guiding movement of a container


15


along the process path


10


responsive to movement of the disk


16


. As the disk


16


moves responsive to activation of the prime mover


24


, the container


15


moves along the lane


28


from one processing station to another to complete determination of the item of interest in the sample.




In the illustrated embodiment, there are a first processing lane


28


and a loading lane


30


in the process path


10


. Complimentary portions of the lanes


28


and


30


are formed in both the cover


12


and the base


14


. Because these two lanes


28


and


30


are substantially concentric, the desk


16


, which is adjacent to both lanes


28


and


30


, and its slots


18


are dimensioned to accept and to support containers


15


disposed in both the process lane


28


and the loading lane


30


at substantially the same circumferential position, while being radially offset, on the disk


16


. In an exemplary embodiment, the lanes


28


and


30


have a width of about 0.279 inches at the top and have a draft angle of about 1.5 degrees.




As shown in

FIGS. 18A

,


18


B and


18


C, in one embodiment, the loading lane


30


accepts and orients containers


15


from a container


15


supply or hopper


102


. A disk


104


including a projection


106


is moved within the hopper


102


by a prime mover


108


. In some embodiments, structures may be included with the hopper


102


, such as a baffle for directing container


15


movement within the hopper


102


responsive to disk


104


movement, an “inherent flat spring” actuated by a cam driven mechanism associated with the disk


104


to move containers


15


within the hopper


102


, and the like, to facilitate movement of the containers


15


. As the disk


104


moves within the hopper


102


, the projection


106


is inserted through the top surface


42


of a container


15


in the hopper


102


. The projection


106


carries the container


15


toward a loading mechanism


110


, which may include a mover


111


, such as a barrel cam and the like, for moving a container


15


from the hopper


102


toward the loading lane


30


. As the container


15


approaches the loading lane


30


, in one embodiment, another mover


112


, such as a solenoid-driven rod and the like, moves the container


15


into a slot


18


in the disk


16


at the loading lane


30


. Alternatively, the container


15


may, move from an end of the mover


111


into a slot


18


in the disk


16


at the loading lane


30


under the influence of gravity.




In an exemplary embodiment, the hooper


102


is made from Lexan WR2210 (GE Plastics of Pittsfield, Mass.) with a black SPI B1 finish and has a volume substantially within the range of about 396 to about 540 cubic inches, thereby allowing the hopper


102


to hold approximately 1000 containers


15


. The disk


104


is made from Lexan 500 with a finish of gray SPI B1 and the projection


106


is made from Lexan WR2210 with a finish of black SPI B1. The disk


104


includes four projection


106


mounts spaced equidistantly along a circumference of the disk


104


, i.e. every 90 degrees, at a radius of about 4.5 inches from a center of the disk


102


. To assist movement of containers


15


within the hopper


102


, the disk


102


includes a plurality, such as four, of nubs having a spherical radius of about 0.165 inches spaced equidistantly along a circumference of the disk


104


, i.e. every 90 degrees, at a radius of about 3.312 inches from a center of the disk


102


. The projection


106


has a nominal thickness of about 0.1 inches and a length of about 0.9 inches. The projection


106


is aligned substantially tangentially to a 4.5 inch radius of the disk


102


. The mover


108


may be No. 78431-101 from Pacific Scientific of Elgin, Ill. The mover


111


includes a screw made from Delrin 500 having a black SPI B1 finish. The screw is about 7.126 inches long and has 18 threads of a diameter measuring about 0.706 inches and of a pitch of about 0.394 inches. The screw is connected to a drive gear made from Celcon M90 having a finish of black SPI B1. The drive gear is an involute gear having 24 teeth with a diametral pitch of about 32, a pressure angle of about 20 degrees and a pitch diameter of about 0.75 inches. The mover


112


may be No. 78851-102 available from Haydon Switch & Instrument of Waterbury, Conn. In other embodiments, No. 78425-101 available from SPM/Portland of Hillsboro, Oreg. may be used for some of the components.




As shown in

FIGS. 7A and 7B

, the container


15


includes a sample receiving chamber


32


and a pair of support surfaces


34


A and


34


B connected with the sample receiving chamber


32


. As shown in

FIG. 8

, the support surfaces


34


A and


34


B rest on portions of the disk


16


which bound the slot


18


. The chamber


32


is formed by two sets of side walis


36


A,


36


B,


38


A and


38


B and a bottom wall


40


. In an exemplary embodiment, the largest external distance between the side walls


36


A and


36


B, which have a rib width of about 0.020 inches, is about 0.26 inches, the largest external distance between the side walls


38


A and


38


B is about 0.44 inches, the support surfaces


34


A and


34


B extend a distance measuring about 0.085 inches from the side walls


38


A and


38


B, respectively, the maximum length of the container


15


is about 1.445 inches, an open end of the sample receiving chamber


32


measures about 0.391 inches by about 0.219 inches, a nominal thickness of the walls


36


A,


36


B,


38


A and


38


B is about 0.030 inches, an inside depth of the sample receiving chamber


32


is about 1.34 inches having a volume of about 1.4 ml and a volume of the sample receiving chamber


32


at a location, from which determination measurements are made, measuring about 0.699 inches from a bottom of the container


15


is about 0.45 ml. A top surface


42


of the container


15


is located a distance measuring about 0.18 inches from the support surfaces


34


A and


34


B. The container


15


may be made from Escorene 3345-E5 (Exxon, Houston, Tex.) or Montell PD701N (Wilmington, Del.) with an internal finish of polished SPE/SPE 1 B-2.




Returning to

FIGS. 4 and 8

, cooperation among the container


15


, the slots


18


in the disk


16


and the lanes


28


and


30


facilitate movement of the container


15


along the process path


10


. Specifically, the dimensions of the container


15


, the slots


18


and the lanes


28


and


30


are predetermined such that the support surfaces


34


A and


34


B of the container


15


radially slidingly engage the disk


16


adjacent to the slot


18


in which the container


15


is disposed while the container


15


itself is restrained from rotation within the slot


18


. In one embodiment, the process lane


28


has a radius of about 27.6 inches and a width of about 0.28 inches while the loading lane


30


has a smaller radius but a similar width. The container


15


is disposed such that axes of the side walls


36


A and


36


B are positioned substantially radially with respect to the process path


10


and the support surfaces


34


A and


34


B are aligned substantially circumferentially with respect to the process path


10


. In this manner, as the disk


16


moves responsive to activation of the prime mover


24


, the container


15


within the slot


18


moves substantially tangentially to the process path


10


within the lanes


28


and


30


.




As the process path


10


may be used with biological samples, it is desirable to maintain the process path


10


, or portions thereof, at a suitable temperature, such as 37 degrees Celsius, to facilitate determination of the item of interest. Thus, a heater (not shown), such as an electric heater and the like, may be thermally associated with the process path


10


. In an exemplary embodiment, a plurality of electric resistive flexible strip heaters may be applied, such as by a suitable adhesive and the like, to the cover


12


and/or the base


14


of the process path


10


. These heaters apply sufficient thermal energy to the process path


10


such that the contents of the container


15


is maintained at the desired temperature. Also, because the loading lane


30


is part of the process path


10


, it is possible to bring the container


15


to the desired temperature prior to addition of anything to the container


15


. For example, if determination of an item of interest in a sample is performed optimally at a given temperature, the container


15


in the loading lane


30


can be brought to that given temperature at a certain time period after introduction of the container


15


from the hopper to the loading lane


30


but before the container


15


is needed to perform the desired determination. Suitable temperature control devices, such as thermistors and the like, are also provided along the process path


10


. Additionally, in some embodiments, materials, such as reagents and the like, to be added to the container


15


may be heated prior to addition to the container


15


. In some cases, the material delivery apparatus, such as a fluid conduit and the like, may be associated with appropriate heaters and heat sensors.




When a container


15


is needed to perform a given item of interest determination, the container


15


is moved from the loading lane


30


to the process lane


28


. This function is performed at location


48


shown at

FIG. 4

To move the container


15


from the loading lane


30


toward the process lane


28


, as shown in

FIG. 10

, a prime mover


44


, mounted on the process path


10


, is operated. A container


15


engaging member


46


operatively connected with the prime mover


44


bears against the side wall


36


A of the container


15


and moves the container


15


radially outward with respect to the disk


16


within the slot


18


from the loading lane


30


towards the process lane


28


responsive to activation of the prime mover


44


. In an exemplary embodiment, the member


46


is made from 6061-T6 aluminum with a MIL-A-63576, Type I finish. The member


46


may include structures, such as a slot, which mate with complimentary structures, such as a pin, on the prime mover


44


to provide desired alignment of the mover


44


and the arm


46


and to limit undesired movement, such as rotation, of the member


46


. Operation of the prime mover


44


causes the member


46


to move a distance of about 0.5 inches with a minimum starting force of about 7.08/0.25 gm/oz and a minimum ending force of about 56.7/2.0 gm/oz.




To accommodate movement of the container


15


, a passageway


50


is formed on the cover


12


and the base


14


connecting the process lane


28


with the loading lane


30


. Once the container


15


is in the process lane


28


, the prime mover


44


moves the container


15


engaging member


46


away from the container


15


just moved to a waiting position to move another container


15


from the loading lane


30


toward the process lane


28


. In an exemplary embodiment, the prime mover


44


is a solenoid, a pneumatically actuated motor, a linear positioner or the like. In a particular embodiment, the prime mover


44


is an electric solenoid with its windings modified such that the solenoid travel occurs without splashing or spilling of container


15


contents.




Now that the container


15


has been moved from the loading lane


30


to the process lane


28


, movement of the disk


16


causes the container


15


to move along the process lane


28


for performance of determination of an item of interest in a sample. In some cases, the sample, such as blood or other bodily fluids, added to the container


15


is in liquid form. Also, in some cases, other substances, such as reagents and the like, are added to the sample in the container


15


during determination of an item of interest in the sample. These other substances may also be in liquid form.




As these liquids are added to the container


15


it is possible that some of the liquids may not end up within the container


15


but may be disposed on the disk


16


or other portions of the process path


10


. To substantially remove these liquids, drain ducts


52


are provided on the base


14


of the process path


10


. These drain ducts


52


are recessed from a groove


54


on the base


14


in which the disk


16


is disposed. In an exemplary embodiment, the drain ducts


52


, about


112


in number, are equidistantly spaced along a circumference of the base


14


, recess a distance of about 0.125 inches from the groove


54


, have an internal angle of about 90 degrees and are about 0.05 inches deep and about 0.1875 inches wide. In some embodiments, the drain ducts


52


may be inclined toward the process lane


28


such that liquid within the drain ducts


52


will move under the influence of gravity toward and into the process lane


28


. In the illustrated embodiment, the drain ducts


52


are oriented in an expected direction of disk


16


rotation. In this embodiment, liquid movement within the drain ducts


52


is encouraged by movement of the disk


16


. Similar drain ducts


52


may be formed on the cover


12


. To facilitate substantial removal of the liquids from the process lane


28


, drain holes


56


are provided in he base


14


at various locations along bottom portions of the process lane


28


.




The process of determining an item of interest in a sample comprises a number of steps. However, given the specific item of interest to be determined, different steps are to be performed. For instance, for determination of a first item of interest, three process steps are to be performed, whereas for a second item of interest, only two process steps are to be performed. These process steps may include, for example, solid,/liquid phase (for example, magnetic) separation, aspiration of container


15


contents, container


15


contents washing, etc. To offer determination of both the first and second items of interest, the process path


10


includes structures for selective automated performance of process steps. However, it is to be noted that the process path


10


includes all structures necessary to perform all process steps for determining a predetermined set of items of interest.




At at least one location along the process lane


28


, structures or elements for providing selective automated performance of a determination of item of interest process step are disposed. As shown in

FIG. 4

, in one embodiment, these structures or elements are located in a bypass region of the process path


10


. In the illustrated embodiment, the process path


10


includes three bypass regions


58


A,


58


B and


58


C. At the bypass regions


58


A,


58


B and


58


C, the process lane


28


is radially expanded with respect to other portions of the process lane


28


. In an exemplary embodiment, the process lane


28


at the bypass regions


58


A,


58


B and


58


C is about 0.65 inches wide radially. The radial expansion of the process lane


28


at the bypass regions


58


A,


58


B and


58


C allows the container


15


to be positioned at multiple places longitudinally along the slot


18


and radially with respect to the disk


16


at the bypass regions


58


A,


58


B and


58


C. Depending on the position of the container


15


within the slot


18


in the disk


16


, the container


15


may or may not participate in the item of interest determination process step performed at the bypass regions


58


A,


58


B and


58


C.




In an alternate embodiment, the structures or elements for providing selective automated performance of a determination of item of interest process step may include routines, such as those embodied in software, hardware and the like, for selectively activating or deactivating certain process path


10


elements, such as a wash zone and the like, selectively moving process path


10


elements into and out of a process step performance position with respect to the process path


10


, such as moving a magnet and the like, or any appropriate combination of the methods discussed herein.




The cover


12


also includes structures forming the bypass regions


58


A,


58


B and


58


C on the process path


10


. As shown in

FIGS. 5A and 5B

, a wall


60


on the cover


12


separates the process lane


28


on the cover


12


at the bypass regions


58


A,


58


B and


58


C into a process step performance lane


62


and a process step avoidance lane


64


offset radially on the cover


12


. The wall


60


engages a portion of the side walls


36


A and


36


B adjacent of top surface


42


of the container


15


to guide the container


15


through either the process step performance lane


62


or the process path avoidance lane


64


.




To encourage a desired container


15


into the desired one of the process step performance lane


62


or the process step avoidance lane


64


, a prime mover


44


connected with a container engaging member


46


is provided attached to the process path


10


, as shown in FIG.


9


. The structure illustrated in

FIG. 9

is substantially similar to the construction illustrated in

FIG. 10

, hence the like reference numbers. Activation of the prime mover


44


enables selective radial positioning of the container


15


at either an inner


66


or outer radial edge


68


(

FIGS. 5A and 5B

) of the process lane


28


. Once so positioned, advancement of she disk


16


with respect to the base


14


moves the container


15


into the preselected one of the process step performance lane


62


or the process step avoidance lane


64


.




In some embodiments, the prime mover


44


, and/or the wall


60


may be constructed to take advantage of natural movement of the container


15


in the process lane


16


. For instance, the container


15


may tend to move radially outwardly along the process lane


28


. In this case, the prime mover


44


and/or the wall


60


may be constructed such that a container


15


moved toward the process step avoidance lane


64


moves toward that lane


64


under centrifugal force without any assistance from the prime mover


44


. In this case, the prime mover


44


would only act on a container


15


to be moved into the process step performance lane


62


.




In the illustrated embodiment, the bypass regions


58


A,


58


B and


58


C are positioned along the process lane


28


dependent upon the anticipated frequency of performance and avoidance of a particular process step. This frequency is, in turn, dependent upon a particular step of determinations of items of interest to be performed with the process path


10


. Also, depending upon the determinations to be performed, there may be more or less bypass regions


58


A,


58


B and


58


C provided.




Illustrating further by example, the process lane


28


diverges radially prior to entering the bypass region


58


A (FIGS.


5


A and


5


B). The process lane


28


enters the bypass region


58


A along its outer radial edge. Since performance of the process step occurs at the inboard process step performance lane


62


of the bypass region


58


A, the prime mover


44


associated with the bypass region


58


A moves the container


15


radially inward toward the process step performance lane


62


only if performance of this process step were desired. If performance of this process step were not desired, then the prime mover


44


would not be activated and the container


15


would remain on the outer radius surface of the process lane


28


and move into the process step avoidance lane


64


upon movement of the disk


16


. This construction favors performance of a set of determinations where performance of the relevant process step is required for a minority of the determinations to be performed.




If the set of determinations were to change such that performance of the relevant process step is required for a majority of the determinations to be performed, then it may be desirable to construct the bypass region


58


A substantially similarly to the bypass regions


58


B and


58


C. At the bypass regions


58


B and


58


C, the process lane


28


enters the bypass regions


58


B and


58


C at its inner radial edge. Thus, if the prime mover


44


is not activated, then the container


15


would move under the influence of movement of the disk


16


into the process step performance lane


62


and the process step would be performed. The prime mover


44


would be activated only to move those containers


15


that did not require performance of this process step. Of course, this would represent a minority of the determinations to be performed with the process path


10


.




Once a container


15


is in one of the bypass regions


58


A,


58


B or


58


C, movement of the container


15


through the bypass region


58


A,


58


B or


58


C is controlled by cooperation among the disk


16


, edges of the process step performance and avoidance lanes


62


and


64


and the wall


60


. The container


15


moves substantially tangentially through the process path


10


under the influence of rotation of the disk


16


. The position of the container


15


radially within the radially inner-most one of the process step performance lane


62


(e.g. bypass region


58


A) or the process step avoidance lane


64


(e.g. bypass region


58


B) is maintained by an inner radial edge of the wall


60


. A radius defining this inner radial edge of the wall


60


gradually increases along the wall


60


from a first end


70


to a second end


72


thereof. The container


15


is moved radially outward as the container


15


moves through the bypass region


58


A,


58


B or


58


C. A radius defining an inner edge of the process step performance lane


62


(e.g. bypass region


58


A) and the process step avoidance lane


64


(e.g. bypass region


58


B) also increases from one end of the bypass region


58


A,


58


B or


58


C adjacent the first end


70


of the wall


60


to an opposite end of the bypass region


58


A,


58


B or


58


C adjacent the second end


72


of the wall


60


. Thus, a portion of the container


15


adjacent its top surface


42


is maintained adjacent the wall


60


, thereby maintaining intended positioning of the container


15


within the bypass regions


58


A,


58


B and


58


C.




Once the determination of an item of interest is complete, the relevant container


15


is removed from the process lane


28


and the process path


10


altogether. As shown in

FIG. 11

, a prime mover


74


is connected with the process path


10


. The prime mover


74


drives a container


15


engaging surface


76


which acts on the container


15


adjacent the top surface


42


of the container


15


. The prime mover


74


, which may be a stepper motor and the like, drives the container engaging surface


76


to rotate the container


15


about 90 degrees with respect to the disk


16


. This occurs at location


78


shown in FIG.


4


. The process path


10


at the location


78


is configured to allow axial rotation of the container


15


and includes an aperture


80


having dimensions larger than corresponding dimensions of the container


15


.




In an exemplary embodiment, the prime mover


74


may be a solenoid such as P/N 197855-001 BTA 2 DV 90° available from Lucas Control Systems Products of Vandalia, Ohio. The surface


76


may be made from 6061-T6 aluminum with a MIL-A-63576, Type I finish and moves approximately 90 degrees responsive to operation of the prime mover


74


.




Once the container


15


has been rotated, the support surfaces


34


A and


34


B of the container


15


are no longer in engagement with the disk


16


. Under the influence of gravity, the container


15


falls through the aperture


80


in the process path


10


into a waste receptacle (not shown). In some constructions, a chute may be provided to guide the container


15


from the process path


10


toward the waste container. In other constructions, liquid present in the container


15


may be removed from the container


15


prior to encountering the prime mover


74


.




With the container


15


being removed from the process lane


28


, another container


15


within the same slot


18


on the disk


16


can be moved from the loading lane


30


to the process lane


28


as soon as the relevant slot


18


reaches the location


48


. In some instances, it may not be desirable to remove a container


15


from the process lane


28


once nat container


15


reaches location


78


. In this case, the prime mover


74


will not be activated. Also, a container


15


disposed within the same slot


18


on the disk


16


but in the loading lane


30


Will not be moved from the loading lane


30


to the process lane


28


when the relevant slot


18


reaches location


48


.




In an alternative embodiment shown in

FIGS. 13 and 19

, the disk


16


is constructed to facilitate removal of a container


15


from the process path


10


. In this embodiment, the slots


18


on the disk


16


include an enlarged container


15


removal area


82


. Also, a diverter


84


is disposed in the process lane


28


adjacent to the location


78


. The diverter


84


, along with movement of the disk


16


, urges the container


15


radially outward with respect to the disk


16


toward the container removal area


82


of the slot


18


. The container removal area


82


is wider than the remainder of the slot


18


such that, when the container


15


reaches the container removal area


82


of the slot


18


, gravity causes the container


15


to fall from the disk


16


and the process path


10


through the aperture


80


and into the waste receptacle. However, this embodiment does not allow a container


15


to pass the location


78


and still remain with the disk


16


. But, if it were desirable to allow the container


15


to remain with the disk


16


in this embodiment, then the diverter


84


may be replaced with a prime mover, similar to the prime mover


44


, to move the container


15


within the slot


18


toward the container removal area


82


.




Another construction of the disk


16


, the slot


18


and the container removal area


82


is shown in FIG.


19


. This construction functions in a manner substantially similar to that of FIG.


13


. It is to be noted that, in the embodiment illustrated in

FIG. 19

, an, end of the process lane


28


is defined by the aperture


80


.




Additional features may be incorporated into the process path


10


as desired. For example, liquid level sensing devices, such as radio frequency liquid level sense devices and the like, may be incorporated at positions along the process path


10


where liquid movement may occur. Also, any suitable structures, such as any of those disclosed in U.S. Pat. Nos. 5,358,691, 5,536,471 and 5,482,861 may be added, sometimes with appropriate modifications. Those patents are assigned to the assignee of the present case and the disclosures thereof are incorporated herein in their entirety by this reference.




It may also be desirable to construct the process lane


28


to reduce light in portions of the process lane


28


. In one embodiment, the process lane


28


is constructed such that there is a radial divergence of that lane


28


prior to and following any position on the process path


10


where light, such as chemiluminescently generated light, measurements are performed. Such a radial divergence of the process lane


28


may increase the sensitivity of the light measurer by reducing introduction of stray or ambient light into the light measuring position of the process lane


28


.




The process path


10


described above allows sequential automated performance of multiple determination of item of interest process steps. The motion of a container


15


along the process lane


28


may be executed in discrete steps, that is discrete with respect to time and with respect to position along the process lane


28


. At regular time intervals, such as about 18 seconds, the disk


16


rotates a distance substantially equal to the angular distance between two adjacent slots


18


. This rotation causes each container


15


to move to the position along the process path


10


previously occupied by the container


15


in the adjacent slot


18


. The disk


16


and the container


15


remain stationary for a remainder of the regular time period prior to the next rotation or indexing of the disk


16


. The process lane


28


may be considered as having a fixed number of process positions, positions at which a process step comprising the determination of an item of interest in a sample occur, equal to the number of slots


18


in the disk


16


.




In the examples described here, there are


112


slots


18


in the disk


16


, and consequently the process lane


28


may be considered as having 112 process positions. The total processing time of a container


15


and its contents may be thought of as integral multiples of the index period. For example, if the index period is 18 seconds, a container


15


in the 10th process position has undergone a total of 180 seconds of processing. Similarly, a process step that is performed over 20 process positions takes a total of 360 seconds of process time on an individual container


15


.




An example of process steps that may be performed during determination of an item of interest in a sample may be described by specifying the process position at which each process step occurs, as is provided in the following examples. This example may be more easily understood with reference to FIG.


16


. The dotted line


129


indicates a boundary of a support on which the process path


10


is mounted.




A reagent carousel


131


is located substantially concentrically with the process path


10


and is rotatable. The reagent carousel


131


may include one or more carousels and may provide for axial rotation of individual containers, i.e. magnetic microparticle containers, disposed thereon. In one embodiment, the reagent carousel


131


may include multiple substantially concentric carousels to provide simultaneous and/or shared access of multiple containers by multiple pipette assemblies, such as assemblies


128


and


134


. Such an arrangement may facilitate performance of the Formats discussed later. The reagent carousel


131


may be constructed substantially similarly to the structure disclosed in GB 2,081,118 B issued on Sep. 7, 1983, with appropriate, well known bearings and gear trains being provided as and where needed (See FIG.


24


B), as disclosed on Page 3, lines 86-91 of that patent. In an exemplary embodiment, the carousel


131


may be No. 77829-101 available from SPM/Portland of Hillsboro, Oreg., with appropriate motors available from Pacific Scientific, gears from Turnamatic of Richardson, Tex. and SPM/Portland and sensors from Aromat of Rolling Meadows, Ill.




The reagent carousel may be maintained within a thermostaticly controlled environment. The thermostaticly controlled environment may be provided by an air cooling unit which provides forced cooled al to a housing


133


(

FIGS. 29 and 30

) containing the reagent carousel


131


. In an exemplary embodiment, the housing


133


may be similar to No. 76848 available from General Pattern of Blaine, Minn. This may reduce evaporation of fluid from the containers held on the reagent carousel


131


. To further reduce evaporation, open mouths of the containers may be fitted with a seal


184


as shown in FIG.


25


. The seal


184


may be made of a polymeric material, such as an elastomer and the like, and may include a slit


186


for allowing a pipettor access to the interior of the container.




In one embodiment, the reagent carousel


131


supports a plurality of reagent containers. These containers may be of at least four types, such as microparticle, conjugate, determination specific diluent and pretreatment, dependent upon the type of reagent contained therein.

FIGS. 22

,


23


A,


23


B and


23


C give two exemplary configurations of the containers. A bottom portion


174


of the containers


176


(

FIG. 22

) and


177


(

FIGS. 23A

,


23


B and


23


C) is constructed to fit with mating portions of the reagent carousel


131


.




As shown more clearly in

FIGS. 24A and 24B

, the bottom portion


174


of the container


177


bears a projection


178


which engages a complementary portion


188


of the reagent carousel


131


. The engagement between the projection


178


and the portion


188


of the reagent carousel


131


provides a user who is placing the container


177


on the reagent carousel


131


with positive feedback, i.e. tactile feel, indicative of proper positioning of the container


177


with respect to the carousel


131


.




As shown in

FIG. 24B

, the portion


188


of the carousel


131


is operatively connected by a shaft


191


with a drive gear


190


which drivingly engages a gear


202


which is connected with a prime mover (not shown). The gear


202


engages all drive gears


190


associated with the carousel


131


. Operation of the prime mover moves the gear


202


which, in turn, moves the gear


190


. Movement of the gear


190


causes axial rotation, which may be bi-directional, of the portion


188


and the container


177


. The shaft


191


also electrically contacts a plate


204


which is electrically connected with a conductor


206


. In this manner, the plate


204


and the conductor


206


, and possibly the portion


188


of the carousel


131


, if it is electrically conductive, comprise a portion of a radio frequency liquid level sense mechanism with determines a fluid level inside the container


177


.




To further facilitate manipulation of the container


177


, a substantially annular rib


180


(

FIGS. 23A

,


23


B and


23


C) may be provided on an outer surface of the container


177


. Also, if it were desirable to maintain the container contents in a substantially homogeneous state, i.e. magnetic particles substantially uniformly dispersed in a liquid medium, then at least one fin


182


(

FIGS. 24A and 24B

) may be provided on an interior, fluid facing surface of the container


177


to agitate container contents upon axial rotation, as discussed above, of the container


177


.




Illustrating constructions of the containers and seals with specific examples, the containers may be made from DOW 30460M HDPE or Chevron 90512 HDPE with a finish of SPI A3. The fins


182


may have a finish of SPI C1. The seals may be made from Lexington Medical 3401005 EPDM. The containers may have a neck inner diameter measuring about 1.069 inches. The rib may have a thickness of about 0.025 inches, a width, from an inner wall of the container, measuring about 0.31 inches, a top geometry measuring about 45 degrees, and a bottom geometry tapering to a center at an angle of about 48 degrees. The seal may have a diameter of about 1.094 inches when installed with a container, a maximum thickness of about 0.070 inches at a centerline of the seal, and a reinforced hinge section measuring about 0.025 inches thick by about 0.062 inches deep from an underside of a pipettor contact area on the seal. The slit on the seal may comprise two slits having a length of about 0.5 inches through a center of the seal and offset about 90 degrees from each other.




To facilitate identification of the containers, at least some of the containers may bear a label


133


A,


133


B, or


133


C, substantially similar to those shown in

FIGS. 21A

,


21


B and


21


C. The labels


133


A,


133


B and


133


C include a high density data carrier


135


A,


135


B and


135


C, respectively, which includes information to facilitate performance of the determinations.




In a specific embodiment, the high density data carrier


135


A,


135


B and


135


C is a two dimensional bar code utilizing PDF


417


technology to provide desired data capacity. This technology allows for inclusion of more information than a common one dimensional bar code. Usage of such a high density data carrier


135


A,


135


B and


135


C provides structural flexibility, i.e. individual containers for a given determination do not have to be physically joined together. The data carrier


135


A,


135


B and


135


C contains information desirable for performance of a given determination. This information may include master lot number, container lot number, container contents, i.e. reagent, lot number and expiration date, calibration curve data, container contents type, etc. The information may also contain a serial number specific to the particular container to facilitate tracking of process path


10


resources.




In the illustrated embodiment, the data carrier


135


A is used with magnetic microparticle containers and holds approximately 185 characters of information. The data carrier


135


A is approximately 1.5 inches tall and about 0.75 inches wide, as viewed by the bar code reader. Because the microparticle container is rotated as discussed above, this rotation may be utilized while reading the data carrier


135


A. In this case, the orientation of the data carrier


135


A with respect to the bar code reader may not be important.




The data carriers


135


B and


135


C of the illustrated embodiment comprise two dimensional bar codes containing about 15 characters of information each. The data density of the carrier


135


B and


135


C is adjusted to allow the carrier


135


B and


135


C to be about 0.7 inches high. Furthermore, the data carrier


135


B and


135


C is printed with error correction, X bar, Y bar and a column count that allows the carrier


135


B and


135


C to be about 3.125 inches wide. In this manner, the data carrier


135


B and


135


C can be disposed along an outer circumference of a container such that the carrier


135


B and


135


C is accessible to the bar code reader through approximately 220 to approximately 270 degrees of visibility, depending on container size. Alternatively, instead of the carrier


135


B which includes only one bar code, the data carrier


135


C includes a plurality of repetitions of a similar, but narrower in form bar code with gaps between adjacent code repetitions. Additionally, various modifications of the data carriers


135


A,


135


B and


135


C are also possible. For instance, one dimensional bar codes could be used, but the surface area of the one dimensional bar code would have to be sufficient for the amount of data contained in the two dimensional bar code.




EXAMPLE




Determining an Item of Interest in a Sample




The process path


10


illustrated in

FIG. 1

is utilized to perform a sequence of process steps, executed with a index period of about 18 seconds. Each index step comprises about 1 second of rotation of the disk


16


(and consequent motion of the containers


15


disposed within the disk


16


) and about 17 seconds during which the containers


15


are stationary at their respective process positions. The process step performed at each process position is as follows:

















Process




Process







Position




Step




Description











 1




Container




Container 15 moved from loading







15 load




lane 30 to process lane 28 as








required






 1




Sample




Sample deposited into container







Pipettor




15 by pipetting system 128. The








sample may be obtained from








position 130A or 130B which are








located on appropriate conveyors








sample handlers or structures








associated with a laboratory








automation system






 2




Reagent




Reagent obtained from reagent







Pipettor 1




carousel 131 deposited into








container 15 by pipetting system








132. Liquid present in the








pipetting system 132 may also be








added to the container 15.






 3




Mixer




Contents of container 15 are








mixed by a device 86 imparting








motion to the container 15






 4-23




Incubation




Contents of container 15 are








incubated at a controlled








temperature, about 37 degrees








Celsius






 24




Sample




Sample may be aspirated from







Pipettor




container contents 15 by pipetting system








128 for deposition into a second








container 15 at position 1






 25-39




Incubation




Contents of container 15 are








incubated at a controlled








temperature






 40




Bypass




Container 15 is selectively







region 58A




positioned at entry to







start




performance lane 62 or avoidance








lane 64 of bypass region 58A






 41




Wash




Container 15 in performance lane







zone 1




62 undergoes magnetic separation








and fluid addition






 42




Wash




Container 15 in performance lane







zone 1




62 undergoes magnetic separation,








container 15 contents aspiration








and fluid addition






 43




Wash




Container 15 in performance lane







zone 1




62 undergoes magnetic separation,








container 15 contents aspiration








and fluid addition






 44




Wash




Container 15 in performance lane







zone 1




62 undergoes magnetic separation








and container 15 contents








aspiration






 45.5




Bypass




Performance lane 62 and avoidance







region




lane 64 of bypass region 58A







58A end




merge (midway between positions








45 and 46)






 46




Container 15




New containers 15 are loaded into







load into




loading lane 30







loading







lane 30






 48




Reagent




Reagent selectively deposited







Pipettor 2




into container 15 by pipetting








system 134






 49




Mixer




Contents of container 15 are








mixed by a device 86 imparting








motion to the container 15






 50-62




Incubation




Contents of container 15 are








incubated at a controlled temperature






 63




Bypass




Container 15 is selectively







region 58B




positioned at entry to








performance lane 62 or avoidance








lane 64 of bypass region 58B






 64




Wash




Container 15 in performance lane







zone 2




62 undergoes magnetic separation








and fluid addition






 65




Wash




Container 15 in performance lane







zone 2




62 undergoes magnetic separation,








container 15 contents aspiration








and fluid addition






 66




Wash




Container 15 in performance lane







zone 2




62 undergoes magnetic separation,








container 15 contents aspiration








and fluid addition






 67




Wash




Container 15 in performance lane







zone 2




62 undergoes magnetic separation








and container 15 contents








aspiration






 68




Bypass




Performance and avoidance lanes







region




62 and 64 of bypass region 58B







58B end




merge






 69-70




Incubation




Contents of container 15 are








incubated at a controlled








temperature






 71




Reagent




Reagent selectively deposited







Pipettor 2




into container 15 by pipetting








system 134






 72




Mixer




Contents of container 15 are








selectively mixed by a device 86








imparting motion to the container 15






 73-86




Incubation




Contents of the container 15 are








incubated at a controlled








temperature






 75




Motor/




Gear 22 on prime mover 24 engages







Encoder




teeth 20 on disk 16 at this








position






 77.5




Home




Electrical, magnetic, optical, or







Sensor




other sensor 136 is present to








generate signal corresponding to








the position of the disk 16






 86




Bypass




Container 15 is selectively







region 58C




positioned at entry to








performance lane 62 or avoidance








lane 64 of bypass region 58C






 87




Wash




Container 15 in performance lane







zone 3




62 undergoes magnetic separation








and fluid addition






 88




Wash




Container 15 in performance lane







zone 3




62 undergoes magnetic separation,








container 15 contents aspiration








and fluid addition






 89




Wash




Container 15 in performance lane







zone 3




62 undergoes magnetic separation,








container 15 contents aspiration








and fluid addition






 90




Wash




Container 15 in performance lane







zone 3




62 undergoes magnetic separation,








and container 15 contents aspiration






 91




Bypass




Performance and avoidance lanes







region




62 and 64 of bypass region 58C







58C end




merge






 91-93




Incubation




Contents of container 15 are








incubated at controlled








temperature






 94




Pre-Trigger




Reagent added to container 15 and







and




mechanically mixed







Mixer






 95-97




Incubation




Contents of container 15 are








incubated at controlled








temperature






 98




Shutter,




Indicator reaction (such as







reader,




chemiluminescent reaction)







and




triggered and read with magnetic







trigger




particles pulled out of solution








with magnet. Shutter blocks








light.






 99




Magnet




Magnetic particles are held at a








wall of the container 15






100




Liquid




Magnetic particles are held at a







Waste




wall of the container 15 and all







Aspirate




liquid in container 15 is








aspirated and discarded






109




Container 15




Container 15 selectively removed







unload




from process lane 28






111




Container 15




System optically verifies that







unload




slot 18 in process lane 28 is







sensor




vacant prior to loading of second








container 15














Adding more specificity to the example, in a particular embodiment, the determination of an item of interest in a sample is an immunoassay. When the process path


10


is used to perform an immunoassay, the container


15


is moved into the process lane


28


at position


1


. Also at position


1


, a known quantity of sample (for example, 50 μl of blood) is deposited into the container


15


by a pipetting system


128


. The pipetting system


128


comprises a pipettor, which may be substantially similar to the pipettors


116


A,


116


B and


116


C, mounted on an arm for movement up and down and angularly, as shown in FIG.


16


.




After indexing the container


15


to position


2


, a known quantity of a first reagent, possibly along with an amount of fluid present in the pipetting system


132


, is deposited into the container


15


by a second pipetting system


132


. The first reagent may contain magnetically responsive microparticles coated with antibodies or other binding substances that specifically bind to the item of interest in the sample. The first reagent may be added with an assay specific diluent. In some cases, the first reagent and a conjugate, possibly along with an amount of fluid present in the pipetting system


132


, may be added at position


2


.




At position


3


, a mechanical device


86


(illustrated in

FIG. 12

) is provided to mechanically move the container


15


and cause mixing of the contents of the container


15


. The mechanical mixing device


86


includes a bore


88


formed within a body


89


, which is eccentrically formed in the illustrated embodiment, that moves axially and rotatably under the influence of a prime mover


90


connected with the body


89


. When the prime mover


90


is activated, the body


89


rotates clockwise, and a protrusion


92


connected with the prime mover


90


moves within a slot


94


in a second body


96


. The second body


96


rotates freely about a drive shaft of the prime mover


90


.




As the protrusion


92


moves within the slot


94


, the body


89


and the bore


88


move toward the bottom


40


of the receptacle


15


as the body


89


rotates. When the body


89


and the bore


88


move toward the container


15


, the bore


88


engages the bottom


40


of the container


15


and imparts an orbital (but not rotational) motion to the bottom


40


of the container


15


. The portions of the container


15


adjacent the top surface


42


remain relatively stationary within the slot


18


in the disk


16


.




The mechanical motion imparted to the container


15


mixes the sample with the first reagent. After the contents of the container


15


have been mixed for a predetermined time period, the prime mover


90


rotates its drive shaft counterclockwise, causing the protrusion


92


to move in an opposite direction within the slot


94


, thereby moving the first body


89


, the bore


88


and the second body


96


away from the bottom


40


of the container


15


.




Illustrating further with a specific example, in one embodiment, the body


89


is made of PEEK with a black finish, the protrusion


92


is made of AISI 301 stainless steel with a #10 passivated finish, the second body


96


is made of Acetron GP with a white finish and the slot


94


has a #32 finish. The bore


88


in the body


89


is offset from an axis of the body


89


and has a radius of about 0.020 inches. An interface between the body


89


and the container


15


provides a minimum of about 0.05 inches of eccentric rotation of the container


15


. The slot


94


provides a rise of about 0.315 inches over a rotation of the second body


96


of about 226.8 degrees. The prime mover


90


is a 3 phase,


8


pole, Y connected DC brushless motor P/N DR538-504 available from Shinano Kenshi of California. The prime mover


90


is supplied with a 36 Volt potential and operates substantially within the range of about 500 to about 5500 rpm's with a torque constant of about 620 g·cm/A.




The container


15


is freed from the bore


88


and processing of the container


15


contents continues. Subsequently, the container


15


contents is incubated for a predetermined time period.




At position


24


, depending upon he particular item of interest in the sample to be determined, the first pipetting system


128


may withdraw a portion of the contents of the container


15


for deposition into another container


15


located at position


1


. This may be appropriate when a particular determination requires pretreatment, such as pre-heating, heated incubation with a first reagent prior to second reagent introduction, and the like, prior to introduction of magnetically responsive microparticles comprising the first reagent.




At position


37


, the process path


10


selectively positions the container


15


for performing or avoiding a series of magnetic separation and wash steps. Structures for performing the wash and separation comprise a wash station


114


, shown in

FIGS. 14 and 15

.




Each wash station


114


includes a plurality, 3 in the illustrated embodiment, of movable pipettors


116


A,


116


B and


116


C and at least one stationary nozzle (not shown) for moving fluids at least one of into and out of the container


15


. In some embodiments, the movable pipettors


116


A,


116


B and


116


C may be used to move fluids out of the container


15


while the at least one stationary nozzle moves fluid into the container


15


. Sensors, such as thermistors and the like, may be operatively associated with the pipettors


116


A,


116


B and


116


C to verify fluid movements.




The pipettors


116


A,


116


B and


116


C move liquids both into and out of the container


15


whereas the nozzle only moves liquid into the container


15


. The movable pipettors


116


A,


116


B and


116


C are connected to a common base plate


118


which moves with respect to the cover


12


under the influence of a prime mover


120


, such as a stepper motor and tile like. Responsive to the prime mover


120


, the pipettors


116


A,


116


B and


116


C move into and out of the container


15


. Suitable fluid delivery conduits, not shown, are connected with the pipettors


116


A,


116


B and


116


C and the nozzle. The pipettors


116


A,


116


B and


116


C are spring-loaded to facilitate their replacement and to cushion any contact between the pipettors


116


A,


116


B and


116


C and another surface, such as the bottom


40


of the container


15


and the like.




The pipettors


116


A,


116


B and


116


C are movable to remove fluid from the container


15


. Because the item of interest is connected with the magnetic particles, a magnet assembly


122


is also included a the wash station


114


. The magnet assembly


122


is disposed in a receptacle


124


in the base


14


. The magnet assembly


122


includes a portion of the performance lane


62


and holds a plurality of permanent magnets


126


. In an exemplary embodiment, the assembly


122


is made from 6061 T6 aluminum with a finish of MIL-A-63576 Type I and the magnets


126


are neodymium Iron Boron (NdFeB) magnets with a residual flux density (Br) substantially within the range of about 12.1 to about 13.2 KG, a coercive force (Hc) substantially within the range of about 11.0 to about 12.0 KOe, an intrinsic coercive force (Hci) substantially within the range of about 17.0 to about 19.0 KOe and a total energy product (BHmax) substantially within the range of about 34.0 to about 41.0 MGOe. The field intensity of the magnets


126


at a distance of about 0.030 inches from the container


15


is about 4470 Gauss and at a distance of about 0.176 inches from the container


15


is about 1570 Gauss.




At the wash station


126


, the magnets


126


hold the magnetic particles, and thereby the item of interest, against a side wall


36


A or


36


B of the container


15


. This allows removal of contents of the container


15


other than the magnetic particles and the item of interest bound to the magnetic particles. In some constructions, the pipettors


116


A,


116


B and


116


C may be positioned such that the pipettors


116


A,


116


B and


116


C move substantially along a central axis of elongation of the container


15


, may be biased away from a side wall


36


A or


36


B against with the magnetic particles are held, or otherwise constructed to reduce the chances of the pipettors


116


A,


116


B and


116


C removing magnetic particles and the item of interest bound to the magnetic particles from the container


15


.




In an exemplary embodiment, the pipettors


116


A,


116


B and


116


C are made from Inconel. The pipettors


116


A,


116


B and


116


C are disposed such that lnongitudinal center lines of the pipettors


116


A,


116


B and


116


C are offset a distance measuring about 0.029 inches from a center line of the containers


15


into which the pipettors


116


A,


116


B and


116


C are inserted. This offset distances the pipettors


116


A,


116


B and


116


C from magnetic particles within the containers


15


. When the pLpettors


116


A,


116


B and


116


C dispense fluid into the containers


15


, the pipettors


116


A,


116


B and


116


C are located a distance measuring about 0.342 inches from a side wall of the containers


15


adjacent the magnets


126


. The pipettors


116


A,


116


B and


116


C are mounted with springs so as to absorb up to 0.1 inches of overdrive. The pipettors


116


A,


116


B and


116


C are fluidly connected with a valve which allows for bubble flushing without use of a container


15


. The stationary nozzle is made of 0.031 inch inner diameter PEEK tubing. The base plate


118


is a two piece, thermally bonded assembly of acrylic with a clear Iridite finish on top and an opaque finish on the bottom to allow fluid visibility and light protection for a chemiluminescence reader.




If, for a particular determination, magnetic separation and washing is required at position


37


, the container


15


is moved to the performance lane


62


. Containers


15


in the performance lane


62


undergo, at each processing position between


41


and


44


, magnetic separation (effected by permanent magnets


126


at fixed locations adjacent to the performance lane


62


), fluid asorration, and fluid dispensing, performed by fluid handling devices introduced through an opening


93


(

FIG. 1

) in the cover


12


. In one embodiment, one of these wash stations (position


41


) includes only a magnetic separation and fluid dispensing step that introduces a wash buffer to the container


15


. In some cases, wash buffer or other fluid is added such that the amount of fuild present within the container


15


facilitates separation (magnetic) of the particles from the fluid in the container


15


. At positions


42


and


43


, separation, fluid aspiration, and fluid dispensing occur. In position


44


, the magnetic particles are separated from the fluid in the container


15


by magnets


126


and fluid is aspirated. In this example, these steps would remove substantially all substances within the container


15


that have not bound to binding conjugate elements on the magnetic particles deposited as the first reagent. Containers


15


within the avoidance lane


64


are undisturbed and continue incubation. The performance and avoidance lanes


62


and


64


merge between positions


45


and


46


.




A second reagent may be deposited into the container


15


at location


48


(

FIG. 4

) by a third pipetting system


134


, again followed by a mechanical device


86


at position


49


to mix the container


15


contents. The second reagent may include an indicator substance, such as a chemiluminescent substance, linked to binding elements that also bind to the item of interest (remaining occurrences of which are bound to the magnetic particles of the first reagent). The contents of the container


15


are incubated at positions


50


-


59


.




The second bypass region


58


B begins at position


60


, where the container


15


may selectively automatically undergo a set of magnetic separations, fluid aspirations, and fluid dispensing steps.




The third pipetting system


134


may deposit a third reagent into the container


15


at position


71


, with subsequent mixing at position


72


and incubation between positions


73


and


86


.




The third bypass region


58


C begins at position


86


, where the container


15


may selectively automatically undergo a set of magnetic separations, fluid aspirations and fluid dispensing steps.




In one embodiment, where it is assumed that substantially a majority of the containers


15


will undergo magnetic separation, fluid aspiration, and fluid dispensing at positions


87


-


90


, no bypass region


58


C may be provided at these locations. For example, these step would cause the removal of substantially all indicator (chemiluminescent) substances that are not bound to the magnetic particles (via the analyte of interest), yielding a container


15


holding indicator substance in an amount indicative of the amount of the item of interest in the initial sample deposition. However, in some determinations, it is desirable to avoid those process steps.




A pretrigger reagent may be deposited by a fluid dispensing device at position


94


.




A fluid dispensing device will deposit a triggering agent at position


98


, which causes the indicator reaction to occur. For example, a chemiluminescent substance releasing reagent may be deposited at position


94


, which causes the release of the indicator (chemiluminescent) substance from the magnetic particles.




The contents of the container


15


are incubated between positions


95


and


97


, inclusive.




Position


98


may also include a magnet, which separates or removes substantially all of the magnetic particles from the fluid within the container


15


. The magnet holds substantially all of the magnetic particles against a side wall


36


A or


36


B of the container


15


prior to reading of light from the chemiluminescent substance. Preferably, all of the magnetic particles are removed from a path of chemiluminescent photons from the chemiluminescent substance, which remains in solution in the fluid in the container


15


, to a light detection apparatus


138


. This read step is substantially similar to that described in EP 0 371 265 B1 issued Jan. 1, 1994. The introduction of the triggering reagent would initiate a chemiluminescent reaction which would be detected and quantified by an optical detection system (not shown) such as a photomultiplier tube or photon counting system.




In an exemplary embodiment, the apparatus


138


may comprise a reader assembly such as No. 73202 available from Thorn EMI of Rockaway, N.J., a photomultiplier tube such as No. 78252-101 available from Hammamatsu of Middlesex, N.J. and a substantially light-tight shutter operable by a plunger such as No. 78200-101 available from Ironwood Industries of Libertyvile, Ill. and a motor such as No. 78851-101 available from Haydon Switch & Instrument of Waterbury, Conn.




The embodiment described in the following examples demonstrates its utility in processing multiple assays of different formats and timing requirements within a common process path


10


. In these examples, the embodiment described enables the execution of at least the following four assay formats, the first three of which may be executed simultaneously with no degradation in processing capacity.















Format A














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (18 minutes)




 4-63







Separation and wash




64-67







Second reagent Introduction and




71-72







mixing







Second incubation (4 minutes)




73-86







Separation and wash




87-90







Pretrigger introduction and




94







mixing







Third incubation (1 minute)




95-97







Trigger and read




98















As an example, Format A may be used to determine at least the following items of interest: antibodies to HCV, antibodies to HIV 1/HIV 2, antibodies to hepatitis B core antigen (HBcAb), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), Hepatitis B Surface Antigen (HBsAg), antibodies to Hepatitis B Surface antigen (HBsAb), alpha-fetoprotein (AFP), Total prostate specific antigen (Total PSA), Free PSA, Thyroid stimulating Hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), beta human chorionic gonadotropin (B-hCG), Free Thyroxine (Free T4), Free triiodothyronine (Free T3), Total T4, Total T3, Prolactin an Ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using his format. For instance, this format may also be used to determine beta human chorionic gonadotropin (B-hCG), prolactin and ferritin.















Format B














Step




Position











Sample Introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (11 minutes)




 4-40







Separation and wash




41-44







Second reagent introduction and




48-49







mixing







Second incubation (11 minutes)




50-86







Separation and wash




87-90







Pretrigger introduction and




94







mixing







Third incubation (1 minute)




95-97







Trigger and read




98















As an example, Format B may be used to determine an item of interest in a sample where a relatively increased degree of sensitivity, as compared with some other formats, is desired. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.















Format C














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (11 minutes)




 4-40







Separation and wash




41-44







Second reagent introduction and




48-49







mixing







Second incubation (4 minutes)




50-63







Separation and wash




64-67







Third reagent introduction and




71-72







mixing







Third incubation (4 minutes)




73-86







Separation and wash




87-90







Pretrigger introduction and




94







mixing







Fourth incubation (1 minute)




95-97







Trigger and read




98















As an example, Format C may be used when the item of interest relates to hepatitis, such as determinations for anti-M, HBcAb-M and HAVAb-M.















Format D














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (7 minutes)




 4-23







Transfer to second container 15




24







in position 1







Second reagent introduction and




 2-3







mixing







Second incubation (11 minutes)




 4-40







Separation and wash




41-44







Third reagent introduction and




48-49







mixing







Third incubation (4 minutes)




50-63







Separation and wash




64-67







Fourth reagent introduction and




71-72







mixing







Fourth incubation (4 minutes)




73-86







Separation and wash




87-90







Pretrigger introduction and




94







mixing







Fifth incubation




95-97







Trigger and read




98


























Format E














Step




Position











Sample introduction




1







First reagent




 2-3







introduction and mixing







First incubation (7




 4-23







minutes)







Transfer portion of




24







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




24-63







contents continues first







incubation (11 minutes)







Second reagent




 2-3







introduction and mixing







with second container 15







contents







First container 15 passes




64-67







through bypass region 58B







Second container 15 first




 4-63







incubation (18 minutes)







Introduction of fourth




71-72







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




64-67







separation and wash







Fourth incubation (4




73-86







minutes — optional) of







first container 15







Third reagent




71-72







introduction into second







container 15 and mixing







First container 15 passes




87-90







through bypass region 58C







Third incubation (4




73-86







minutes) of second







container 15







Pretrigger introduction




94







into first container 15







and mixing







Separation and wash of




87-90







second container 15







Trigger and read value 1




98







(Total Hb) from first







container 15







Pretrigger introduction




94







into second container 15







and mixing







Trigger and read value 2




98







(GlyHb)





















Reported  result

=



value  2


value  1


×
100





















For example, in Format E, it is possible to modify the format by disregarding the first container


15


after the portion of the container


15


contents has been transferred (Position


24


) to the second container


15


. In that case, Format may be used to determine, for example, folate and vitamin B12.















Format F














Step




Position











Sample introduction




1







First reagent




 2-3







introduction and mixing







First incubation (7




 4-23







minutes)







Transfer portion of




24







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




24-63







contents continues first







incubation (11 minutes)







Second reagent




 2-3







introduction and mixing







with second container 15







contents







First container 15 passes




64-67







through bypass region 58B







Second container 15 first




 4-40







incubation (11 minutes)







Introduction of fourth




71-72







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




41-44







separation and wash







Fourth incubation (4




73-86







minutes — optional) of







first container 15







Third reagent




48-49







introduction into second







container 15 and mixing







First container 15 passes




87-90







through bypass region 58C







Third incubation (11




50-86







minutes) of second







container 15







Pretrigger introduction




94







into first container 15







and mixing







Separation and wash of




87-90







second container 15







Trigger and read value 1




98







(Total Hb) from first







container 15







Pretrigger introduction




94







into second container 15







and mixing







Trigger and read value 2




98







(GlyHb)





















Reported  result

=



value  2


value  1


×
100





















This format may be used, for example, to determine at least one of total and and glycated hemoglobin. Also, this format may be modified by disregarding the first container


15


as in Format E.















Format G














Step




Position











Sample introduction




1







First reagent




 2-3







introduction and mixing







First incubation (7




 4-23







minutes)







Transfer portion of




24







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




24-63







contents continues first







incubation (11 minutes)







Second reagent




 2-3







introduction and mixing







with second container 15







contents







First container 15




64-67







separation and wash







Second container 15 first




 4-63







incubation (18 minutes)







Introduction of fourth




71-72







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




64-67







separation and wash







Fourth incubation (4




73-86







minutes — optional) of







first container 15







Third reagent




71-72







introduction into second







container 15 and mixing







First container 15




87-90







separation and wash







Third incubation (4




73-86







minutes) of second







container 15







Pretrigger introduction




94







into first container 15







and mixing







Separation and wash of




87-90







second container 15







Trigger and read value 1




98







(Total Hb) from first







container 15







Pretrigger introduction




94







into second container 15







and mixing







Trigger and read value 2




98







(GlyHb)





















Reported  result

=



value  2


value  1


×
100





















As an example, this format may also be modified as may be done with Format F. With that modification, this Format may be used to determine progesterone, testosterone and estradiol.















Format H














Step




Position











Sample introduction




 1







First reagent




 2-3







introduction and mixing







First incubation




 4-86







Separation and wash




87-90







Pretrigger introduction




94







and mixing







Second incubation




95-97







Trigger and read




98















As an example, this format may be used to determine, among other things, beta human chorionic gonadotropin (B-hCG), prolactin, progesterone, testosterone, estradiol and ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.















Format I














Step




Position











Sample introduction into




1







first container 15,







possibly with diluent







fluid







First reagent




2







introduction into first







container 15, portion of







first container 15







contents moved into







pipettor, remainder of







container continues on







process lane 28,







bypassing all wash







stations, to Position 71







First reagent




 2-3







introduction into second







container 15 and mixing







First incubation of




 4-23







second container 15







Second container 15 first




24-63







incubation (18 minutes)







Introduction of second




71-72







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




64-67







separation and wash







Fourth incubation (4




73-86







minutes — optional) of







first container 15







Third reagent




71-72







introduction into second







container 15 and mixing







First container 15 passes




87-90







through bypass region 58C







Third incubation (4




73-86







minutes) of second







container 15







Pretrigger introduction




94







into first container 15







and mixing







Separation and wash of




87-90







second container 15







Trigger and read value 1




98







(Total Hb) from first







container 15







Pretrigger introduction




94







into second container 15







and mixing







Trigger and read value 2




98







(GlyHb)





















Reported  result

=



value  2


value  1


×
100





















As an example, in Format I, it is possible to modify the format by disregarding the first container


15


after the portion of the container


15


contents has been transferred (Position


24


) to the second container


15


. In that case, Format I may be used to determine, for example, folate and vitamin B12.















Format J














Step




Position











Sample introduction into




 1







container 15, possibly







with diluent fluid







First reagent




2-3







introduction and mixing







First incubation (27




 4-93







minutes)







Pretrigger introduction




94







and mixing







Second incubation (1




95-97







minute)







Trigger and read




98















As an example, Format J may be used to determine, among other things, total hemoglobin.




The embodiments described herein also allow for sample pretreatment which may be performed in at least two ways, indicated as Formats K and L. During performance of sample pretreatment, fluid present in the containers


15


indicated may be processed, after they are no longer significant in the pretreatment steps, in any appropriate manner, such as any of the Formats discussed above. Also, as will become clear later on, both Formats K and L are substantially similarly applicable to the other embodiments of the process path


10


discussed below.















Format K














Step




Position











Sample introduction into




 1







first container 15,







possibly with diluent







fluid







First reagent




2-3







introduction and mixing







First incubation (7




 4-23







minutes)







Transfer portion of




24







contents of first







container 15 to second







container 15 in Position







1







Second reagent




2-3







introduction to second







container 15 and mixing







(optional)







Transfer portion of




24







contents of second







container 15 to third







container 15 in Position 1







Third reagent




2-3







introduction to third







container and mixing







(optional)















As an example, the third container


15


may be processed according to at least one of Formats A to determine, among other things, folace), B, C, H and J.















Format L














Step




Position











Sample introduction into




 1







first container 15,







possibly with diluent







fluid







First reagent




2-3







introduction and mixing







First incubation (7




 4-23







minutes)







Transfer portion of




24







contents of first







container 15 to second







container 15 in Position 1







Second reagent




2-3







introduction to second







container 15 and mixing







(optional)















As an example, the second container


15


may be processed according to at least one of Formats A (to determine, among other things, folate, vitamin B12, confirm HBsAg), B, C, H and J.




In each of the formats discussed above, it is possible to move contents of a first container


15


at Position


2


or


24


into a second container


15


at Position


1


. Thereafter, the first container


15


may or may not be ignored.




It is to be remembered, as pointed out earlier, that the steps of one format may be mixed with steps of another format to arrive at yet further formats. Also, it is to be remembered that the construction of the process path


10


, and its elements and supporting components, allow for selective automated performance (i.e. a particular step may or may not be performed, as desired) of the above-described steps.




These examples demonstrate usefulness of the described embodiments in controlled processing of determinations of items of interest in a sample within a common process path


10


.




As discussed earlier, multiple process paths


10


may be connected to meet specific needs. If the process path


10


were to perform approximately 200 determinations per hour, and if an analyzer (

FIG. 29

) that performed 400 determinations per hour were needed, then two process paths


10


could be connected. One way of doing is described with reference to

FIGS. 17

,


29


and


30


.




As

FIG. 17

illustrates, the process path


10


would be located an space


140


. No supply samples to the process path


10


, a load track


142


and a conveyor


146


are provided connected to a frame


148


defining the space


140


. In some embodiments, at least one of the load track


142


, the conveyor


146


and an unload track


192


may be provided with a cover


194


(FIG.


30


). A carrier


150


supporting multiple sample tubes


152


, which may be any suitable tubes, rides along both the load track


142


and the conveyor


146


. Both the load track


142


and he conveyor


146


move the carrier


150


as indicated by the arrows. A transfer mechanism


154


, such as a solenoid (e.g. linear actuation, driven arm and the like, shifts carrier


150


from the load track


142


to the conveyor


146


.




The carrier


150


moves along the conveyor


146


until the carrier


150


is stopped by a retention member


156


, which is, in the illustrated embodiment, a stepper motor driving a star wheel which mates with the carrier


150


. The pipetting system


128


accesses sample at the position


130


B and supplies that sample to a contiainer


15


on the process path


10


. Of course, suitable identification structures, such as bar codes cn the sample tubes


152


and a bar code reader, can be provided. When the pipetting system


128


, or any of the pipetting systems


128


,


132


or


134


access a fluid, pipetting system pressure can be monitored as described in commonly owned U.S. patent application, Ser. No. 08/572,835 filed on Dec. 14, 1995. The disclosure of that application is Incorporated herein in its entirety. Appropriate liquid level sense devices, such as radio frequency based devices and the like, may also be located in suitable positions.




In an exemplary embodiment, the load track


142


may be No. 77325-101 and the conveyor


146


may be No. 77425-101 both available from Dorner Manufacturing of Hartland, Wis. The unload track


192


may be No. 77525-101 available from SPM/Portland of Hillsboro, Oreg. The retention member


156


may be No. 77476-101 available from Pacific Scientific of Elgin, Ill. The transfer mechanism


154


may comprise a solenoid such as No. 77952 available from Lucas/Ledex of Vandalia, Ohio, a belt such as No. 6R25-M225090 and a pulley such as No. A 6725-020DF0908 both available from Stock Drive Parts of New Hyde Park, N.Y., and a stepper motor such as No. P21NSXS-LSS-NS-07 available from Pacific Scientific of Elgin, Ill.




In some cases, a level of sample in a sample tube


152


may be insufficient for access by the pipetting system


128


. In these cases, the sample within the sample tube


152


may be moved by an operator into another container


208


shown in

FIGS. 31A

,


31


B and


31


C. The container


208


comprises a barrel


210


and a flange


212


. The barrel


210


is dimensioned to fit within the sample tube


152


as shown in FIG.


31


C. The flange


212


is offset from an outer diameter surface of the barrel


210


by a distance sufficient to accommodate any suitable sample tubes


152


. In this way, sample can be moved from the sample tube


152


into the container


203


and the container


208


can be placed within the sample tube


152


. The sample tube


152


bearing the container


203


may then be placed into the carrier


150


. Because the sample is now in the container


208


, the level of the sample is elevated with respect to the level of the sample in the sample tube


152


, thereby facilitating sample access by the pipetting system


128


.




In an exemplary embodiment, the container


208


may be made from DOW 666 polystyrene and is dimensioned to fit within sample tubes having outer diameters substantially within the range of about 0.4 inches through about 0.7 inches. The barrel


210


has an outer diameter measuring about 0.4 inches and a length of about 1.964 inches. The flange


212


has an outer diameter measuring about 0.776 inches, depends from an open end of the container


208


by a distance of about 0.216 inches and is offset from the outer diameter surface of the barrel


210


by a distance of about 0.258 inches.




In some embodiments, the load track


142


is removed and replaced by a sample supply conveyor having a similar retention member


156


. If this were done, then the pipetting system


128


would access sample at position


130


A. If this case, then, in additional embodiments, a carousel


139


may be operatively connected with the frame


148


by a connection member


193


as shown in

FIGS. 26 and 27

. The connection member


193


locates the carousel


189


with respect to the process path


10


such that the pipetting system


128


can also access containers on the carousel


189


at position


130


B. The carousel


189


may be used, for instance, to house determination calibrators and controls and certain samples, such as emergency samples that need to be processed immediately. In an exemplary embodiment, the carousel


189


may be a 2 or 3 part injection molded polymeric (ABS, GE-Cycca or the like) article constructed substantially similar to a TDx® unit dose carousel, an IMx Select® carousel (Abbott Laboratories, Abbott Park, Ill.) and the like.




In some instances, the retention member


156


may not retain the carrier


150


for sample access, but may allow the carrier


150


to move toward an end


158


of the conveyor


146


towards another process path


10


. In this case, the frame


148


includes a connecting structure


160


for operatively coupling one process path


10


to another, or more specifically, one frame


148


holding one process path


10


to another frame


148


holding another process path


10


. In an exemplary embodiment, the connecting structure


160


may be constructed such that two adjacent frames


148


are offset by a distance substantially within the range of about 0.25 inches to about 1.5 inches.




The connecting structure


160


comprises a first bracket


162


and a second bracket


164


. The first bracket


162


is connected with one frame


148


and the second bracket


164


is connected with the another frame


148


. To connect the frames


148


, a fastener, such as a bolt and the like, is placed between aligned apertures


166


in the first and second brackets


162


and


164


. Another fastener is inserted into slots


168


disposed on opposite ends of the brackets


162


and


164


. The conveyors


146


supported by both frames


148


have sufficient tolerance such that more precise alignment of the frames


148


is not required. As a carrier


150


leaves an end


158


of one conveyor


146


, the carrier


150


is supported by an opposing end


196


of an the adjacent conveyor


146


. Once the carrier


150


reaches the end


158


of the last conveyor


146


, the carrier


150


is moved to an unload track


192


(FIG.


29


), constructed and operated substantially similarly to the load track


142


, by another transfer mechanism


197


, which may be substantially similar to the transfer mechanism


154


.




The construction of the process path


10


is also adaptable in other ways to meet other requirements. For example, it may be desirable to provide a process path


10


that performs 100, 50 or any desired number of determination per hour. Viewing this requirement in another way, it may be desirable to provide a process path


10


that fits within a certain physical space, such as a table surface. To meet such requirements, the process path


10


may be scaled, i.e. altered in size or determinations per hour while still including elements discussed above, such as a bypass region, a mixing device, a pipetting system, a wash station and a reader.




Another embodiment is a process path


10


-˜, constructed to perform 100 determinations per hour, and is illustrated in

FIGS. 20A and 23B

. This embodiment utilizes elements substantially similar to those described above, hence the like reference characters. The same index period and assay formats are used, thereby allowing the same reagents to be used. Because of the reduced number of determinations per hour, it is possible to reduce correspondingly the physical dimensions of the embodiment. For instance, whereas the process path


10


of the previous Figures comprises 112 positions, the process path


10


-˜ comprises about 55 positions. In another embodiment, which performs 50 determinations per hour, the corresponding process path comprises approximately 32 positions.




Whereas the determinations performed with the process path


10


are completed without a container


15


passing the same location along the process lane


28


more than once, the containers


15


used with the process path


10


-˜ may pass the same location along the process lane


28


more than once. Depending upon the particular needs to be addressed, the process path may be modified such that a container


15


passes the same location along the process path any appropriate number or times. Of course, depending upon the particular employment, a given container


15


may be positioned in a different one of a performance lane


62


and an avoidance lane


64


of a given bypass region


58


at different times passing through the same bypass region


53


during a given determination.




Illustrating further by example, the following describes the procedures performed at each location along the process path


10


-˜ which performs 100 determinations in an hour. As noted above, a particular container


15


may pass a given location along the process path


10


-˜ more than once. Therefore, Process Position


1


indicates the first time the container


15


encounters Process Position


1


, while Process Position


1


′ indicates the second time the container


15


encounters Process Position


1


. Also, in similar fashion, Process Position


1


″ indicates the third time the container


15


encounters Process Position


1


. Furthermore, the process path


10


-˜ is constructed such that once a container


15


reaches Process Position


46


a first time, the next Process Position reached by the container


15


may be Process Position


1


′, i.e. the container


15


moves from one end of the process path


10


-˜ to an opposite end of the process path


10


-˜.




In the illustrated embodiment of the process path


10


-˜, a second processing lane


170


is included. The second processing lane


170


may be located in any suitable position with respect to the processing lane


28


so that a container


15


can move between the process lane


28


and the process lane


170


. In some embodiments, the position of the process lane


170


may be chosen to maintain the process path


10


-˜ within specified physical dimensions.




A prime mover, which may be substantially similar to the prime movers discussed earlier, is located, in an exemplary embodiment, adjacent position


46


along the process lane


28


. This prime mover is operable to move a container


15


from the process lane


28


to the process lane


170


when desired, viz. for reading a determination reaction, removal of a container


15


from the process path


10


-˜, etc. The process lane


28


may be joined to the process lane


170


by suitable connection structures


172


, such as those associated with a bypass region. In this manner, a container


15


may be selectively automatically moved between the process lane


28


and the process lane


170


. Thus, upon reaching Process Position


46


, a container


15


may move to Process Position


1


of the process lane


28


, or, alternatively, may move from Process Position


46


of the process lane


28


to Process Positions


47


through


55


of the process lane


170


. Once in the process lane


170


, process steps detailed in the example below are performed. Of course, structures, similar to those discussed above, that perform those process steps are disposed along the process lane


170


which has sufficient dimensions to accommodate these structures.




















Process




Process








Position




Step




Description













 1




Container




Container 15 moved from loading








15 load




lane 30, if present, to process









lane 28 as required







 1




Sample




Sample deposited into container








Pipettor




15 by pipetting system 128. The









sample may be obtained from









position 130A or 130B which are









located on appropriate conveyors







 2




Reagent




Reagent obtained from reagent








Pipettor 1




carousel 131 deposited into









container 15 by pipetting system









132







 3




Mixer




Contents of container 15 are









mixed by a device 86 imparting









motion to the container 15







 4-16




Incubation




Contents of container 15 are









incubated at a controlled









temperature, about 37 degrees









Celsius







17




Bypass




Container 15 is selectively








region




positioned at entry to








start




performance lane 62 or avoidance









lane 64 of bypass region







18




Wash




Container 15 in performance lane








zone 1




62 undergoes magnetic separation









and fluid addition







19




Wash




Container 15 in performance lane








zone 1




62 undergoes magnetic separation,









container 15 contents aspiration









and fluid addition







20




Wash




Container 15 in performance lane








zone 1




62 undergoes magnetic separation,









container 15 contents aspiration









and fluid addition







21




Wash




Container 15 in performance lane








zone 1




62 undergoes magnetic separation,









and container 15 contents









aspiration







22




Bypass




Performance and avoidance lanes








region




62 and 64 of bypass region merge








end







23-24




Incubation




Contents of container 15 are









incubated at a controlled









temperature







24




Sample




Sample may be aspirated from








Pipettor




container 15 by pipetting system









128 for deposition into a second









container 15 at position 1







25




Reagent




Reagent obtained from reagent








Pipettor 2




carousel 131 may be deposited









into container by pipetting









system 132







26




Mixer




Contents of container 15 are









mixed by a device 86 imparting









motion to the container 15







27-39




Incubation




Contents of container 15 are









incubated at a controlled









temperature







40




Bypass




Container 15 is selectively








region




positioned at entry to








start




performance lane 62 or avoidance









lane 64 of bypass region







41




Wash




Container 15 in performance lane








zone 2




62 undergoes magnetic separation









and fluid addition







42




Wash




Container 15 in performance lane








zone 2




62 undergoes magnetic separation,









container 15 contents aspiration









and fluid addition







43




Wash




Container 15 in performance lane








zone 2




62 undergoes magnetic separation,









container 15 aspiration









and fluid addition







44




Wash




Container 15 in performance lane








zone 2




62 undergoes magnetic separation









and container 15 contents









aspiration







45.5




Bypass




Performance lane 62 and avoidance








region




lane 64 of bypass region merge








end




(midway between positions 45 and









46)







46




Process




Container moves from Process








lane




Position 46′ of process lane 28








transfer




to Process Position 46 of process









lane 170







46-47




Incubation




Contents of container 15 are









incubated at a controlled









temperature







48




Pre-Trigger




Reagent added to container 15 and








and Mixer




mechanically mixed







49-53




Incubation




Contents of container 15 are









incubated at controlled









temperature







52




Shutter,




Indicator reaction (such as








reader,




chemiluminescent reaction)








and




triggered and read with magnetic








trigger




particles pulled out of solution









with magnet. Shutter blocks









light.







54




Liquid




Magnetic particles are held at a








Waste




wall of the container 15 and all








Aspirate




liquid in container 15 is









aspirated and discarded







55




Container




Container 15 removed from process








15




lane 28








unload















Given these modifications, it is possible to utilize determination formats that are substantially similar to those discussed previously. For the sake of clarity, those formats, as performed by the process path


10


-˜, are listed below.















Format A














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (18 minutes)




 4-17







Container 15 passes through




18-21







bypass region, first incubation







continues







First incubation continues




22-40







Container 15 passes through




41-44







bypass region, first incubation







continues







First incubation continues




45-17′







Separation and wash




18′-21′







Second reagent introduction and




25′-26′







mixing







Second incubation (4 minutes)




27′-40′







Separation and wash




41′-44′







Container 15 transferred from




46′ of 28







process lane 28 to process lane




to 46 of 170







170







Pretrigger in introduction and




48







mixing







Third incubation (1 minute)




49-51







Trigger and read




52







Container 15 evacuate




54







Container 15 removal




55















As an example, Format A may be used to Determine at least the following items of interest: antibodies to HCV, antibodies to HIV 1/HIV 2, antibodies to hepatitis B core antigen (HBcAb), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), Hepatitis B Surface Antigen (HBsAg), antibodies to Hepatitis B Surface antigen (HBsAb), alpha-fetoprotein (AFP), Total prostate specific antigen, (Total PSA), Free PSA, Thyroid stimulating Hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), beta human chorionic gonadotropin (B-hCG), Free Thyroxine (Free T4), Free triiodothyronine (Free T3), Total T4, Total T3, Prolactin and Ferritin. It is to be noted that almost any item of interest discussed herein ray be determined by properly using this format. For instance, this format may also be used to determine beta human chorionic gonadotropin (B-hCG), prolactin and ferritin.















Format B














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (11 minutes)




 4-40







Separation and wash




41-44







Second reagent introduction and




 2′-3′







mixing







Second incubation (11 minutes)




 4′-40′







Separation and wash




41′-44′







Container 15 transferred from




46′ of 28







process lane 28 to process lane




to 46 of 170







170







Pretrigger introduction and




48







mixing







Third incubation (1 minute)




49-51







Trigger and read




52







Container 15 evacuate




54







Container 15 removal




55















As an example, Format B may be used to determine an item of interest in a sample where a relatively increased degree of sensitivity, as compared wish some other formats, is desired. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.















Format C














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (11 minutes)




 4-40







Separation and wash




41-44







Second reagent introduction and




 2′-3′







mixing







Second incubation (4 minutes)




 4′-17′







Separation and wash




18′-21′







Third reagent introduction and




25′-26′







mixing







Third incubation (4 minutes)




27′-40′







Separation and wash




41′-44′







Container 15 transferred from




46′ of 28







process lane 28 to process lane




to 46 of 170







170







Pretrigger introduction and




48







mixing







Fourth incubation (1 minute)




49-51







Trigger and read




52







Container 15 evacuate




54







Container 15 removal




55















As an example, Format C may be used when the item of interest relates to hepatitis, such as determinations for anti-M, HBcAb-M and HAVAb-M.















Format D














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (6 minutes)




 4-17







Transfer to second container 15




24







in position 1







Second reagent introduction and




 2-3







mixing







Second incubation (11 minutes)




 4-40







Separation and wash




41-44







Third reagent introduction and




 2′-3′







mixing







Third incubation (4 minutes)




 4′-17′







Separation and wash




18′-21′







Fourth reagent introduction and




24′-25′







mixing







Fourth incubation (4 minutes)




27′-40′







Separation and wash




41′-44′







Container transferred from




46′ of 28







process lane 28 to process lane




to 46 of 170







170







Pretrigger introduction and




48







mixing







Fifth incubation (1 minute)




49-51







Trigger and read




52







Container 15 evacuate




54







Container 15 removal




55


























Format E














Step




Position











Sample introduction




1







First reagent




  2-3







introduction and mixing







First incubation (7




  4-23







minutes)







Transfer portion of




24







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




 25-17′







contents continues first







incubation (11 minutes)







Second reagent




  2-3′







introduction and mixing







with second container 15







contents







First container 15 passes




18′-21′







through bypass region 58B







Second container 15 first




4-17







incubation (18 minutes)







Introduction of fourth




24′-25′







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




18′-21′







separation and wash







Fourth incubation (4




26′-40′







minutes — optional) of







first container 15







Third reagent




24′-25′







introduction into second







container 15 and mixing







First container 15 passes




41′-44′







through bypass region







Third incubation (4




26′-40′







minutes) of second







container 15







First container 15




46′ of 28 to 46 of 170







transferred from process







lane 28 to process lane







170







Pretrigger introduction




48







into first container 15







and mixing







Separation and wash of




41′-44′







second container 15







Second container 15




46′ of 28 to 46 of 170







transferred from process







lane 28 to process lane







170







Trigger and read value 1




52







(Total Hb) from first







container 15







Pretrigger introduction




48







into second container 15







and mixing







Trigger and read value 2




52







(GlyHb)





















Reported  result

=



value  2


value  1


×
100





















For example, in Format E, it is possible to modify the format by disregarding the first container


15


after the portion of the container


15


contents has been transferred (Position


24


) to the second container


15


. In that case, Format E may be used to (determine, for example, folate and vitamin B12.















Format F














Step




Position











Sample introduction




 1







First reagent




2-3







introduction and mixing







First incubation (7




 4-24







minutes)







Transfer portion of




24







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




 25-17′







contents continues first







incubation (11 minutes)







Second reagent




2-3







introduction and mixing







with second container 15







contents







First container 15 passes




18′-21′







through bypass region 58B







Second container 15 first




 4-40







incubation (11 minutes)







Introduction of fourth




24′-25′







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




41-44







separation and wash







Fourth incubation (4




26′-40′







minutes - optional) of







first container 15







Third reagent




2′-3′







introduction into second







container 15 and mixing







First container 15 passes




41′-44′







through bypass region







Third incubation (11




4′-40′







minutes) of second







container 15







First container 15




46′ of 28 to 46 of 170







transferred from process







lane 28 to process lane







170







Pretrigger introduction




48







into first container 15







and mixing







Separation and wash of




41′-44′







second container 15







Trigger and read value 1




52







(Total Hb) from first







container 15







Second container 15




46′ of 28 to 46 of 170







transferred from process







lane 23 to process lane







170







Pretrigger introduction




48







into second container 15







Trigger and read value 2




52







(GlyHb)





















Reported





result

=



value





2


value





1


×
100





















This format may be used, for example, to determine at least one of total and glycated hemoglobin. Also, this format may be modified by disregarding the first container


15


as in Format E.















Format G














Step




Position











Sample introduction




 1







First reagent




2-3







introduction and mixing







First incubation (6




 4-23







minutes)







Transfer portion of




23







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




25-17′







contents continues first







incubation (12 minutes)







Second reagent




2-3







introduction and mixing







with second container 15







contents







First container 15




18′-21′







separation and wash







Second container 15 first




  4-17′







incubation (18 minutes)







Introduction of fourth




24′-25′







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




18′-21′







separation and wash







Fourth Incubation (4




27′-40′







minutes - optional) of







first container 15







Third reagent




24′-26′







introduction into second







container 15 and mixing







First container 15




41′-44′







separation and wash







Third incubation (4




26′-40′







minutes) of second







container 15







First container 15




46′ of 28 to 46 of 170







transferred from process







lane 28 to process lane







170







Pretrigger introduction




48







into first container 15







and mixing







Separation and wash of




41′-44′







second container 15







Second container 15




46′ of 28 to 46 of 170







transferred from process







lane 28 to process lane







170







Trigger and read value 1




52







(Total Hb) from first







container 15







Pretrigger introduction




48







into second container 15







and mixing







Trigger and read value 2




52







(GlyHb)





















Reported





result

=



value





2


value





1


×
100





















As an example, this format mass also be modified as may be done with Format F. With that modification, this Format may be used to determine progesterone, testosterone and estradiol.















Format H














Step




Position











Sample introduction




 1







First reagent




 2-3







introduction and mixing







First incubation




 4-41′







Separation and wash




42′-44′







Container 15 transfer




46′ of 28







from process lane 28 to




to 46 of 170







process lane 170







Pretrigger introduction




48







and mixing







Second incubation




49-51







Trigger and read




52















As an example, this format may be used to determine, among other things, beta human chorionic gonadotropin (B-hCG), prolactin, progesterone, testosterone, estradiol and ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.















Format I














Step




Position











Sample introduction into




 1







first container 15,







possibly with diluent







fluid







First reagent




 2







introduction into first







container 15, portion of







first container 15







contents moved into







pipettor, remainder of







container continues on







process lane 28,







bypassing all wash







stations, to Position 25′







First reagent




2-3







introduction into second







container 15 and mixing







Second container 15 first




  4-17′







incubation (18 minutes)







Introduction of second




25′-26′







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




18′-21′







separation and wash







Fourth incubation (4




27′-40′







minutes - optional) of







first container 15







Third reagent




25′-26′







introduction into second







container 15 and mixing







First container 15 passes




41′-44′







through bypass region 58







Third incubation (4




27′-40′







minutes) of second







container 15







Pretrigger introduction




48







into first container 15







and mixing







Separation and wash of




41′-44′







second container 15







Trigger and read value 1




52







(Total Hb) from first







container 15







Pretrigger introducticn




48







into second container 15







and mixing







Trigger and read value 2




52







(GlyHb)





















Reported





result

=



value





2


value





1


×
100





















As an example, in Format I, it is possible to modify the format by disregarding the first container


15


after the portion of the container


15


contents has been transferred (Position


24


) to he second container


15


. In that case, Format


7


may be used to determine, for example, folate and vitamin B12.















Format J














Step




Position











Sample introduction into




 1







container 15, possibly







with diluent fluid







First reagent




 2-3







introduction and mixing







First incubation (27




 4-47







minutes - two times along







process lane 28)







Pretrigger introduction




48







and mixing







Second incubation (1




49-51







minute)







Trigger and read




52















As an example, Format J may be used to determine, among other things, total hemoglobin.




The embodiments described herein also allow for sample pretreatment which may be performed in at least two ways, indicated as Formats K and L. During performance of sample pretreatment, fluid present in the containers


15


indicated may be processed, after they are no longer significant in the pretreatment steps, in any appropriate manner, such as any of the Formats discussed above. Also, as will become clear later on, both Formats K and L are substantially similarly applicable to the other embodiment of the process path


10


discussed below.















Format K














Step




Position











Sample introduction into




 1







first container 15,







possibly with diluent







fluid







First reagent




 2-3







introduction and mixing







First incubation




 4-23







(6 minutes)







Transfer portion of




24







contents of first







container 15 to second







container 15 in Position 1







Second reagent




 2-3







introduction to second







container 15 and mixing







(optional)







Transfer portion of




24







contents of second







container 15 to third







container 15 in Position







1







Third reagent




 2-3







introduction to third







container and mixing







(optional)















As an example, the third container


15


may be processed according to at least one of Formats A (to determine, among other things, folate), B, C, H and J.















Format L














Step




Position











Sample introduction into




 1







first container 15,







possibly with diluent







fluid







First reagent




 2-3







introduction and mixing







First incubation (7




 4-23







minutes)







Transfer portion of




24







contents of first







container 15 to second







container 15 in Position 1







Second reagent




 2-3







introduction to second







container 15 and mixing







(optional)















As an example, the second container


15


may be processed according to at least one of Formats A (to determine, among other things, folate, vitamin B12, confirm HBsAg), B, C, H and J.




Another embodiment is a process path


10


′, substantially similar to the previous embodiment, of the process path


10


is constructed to perform 50 determinations per hour. Elements similar to those described earlier, along with the same index period and assay formats are used, thereby allowing use of the same reagents albeit in an embodiment having relatively smaller physical dimensions. Following the examples discussed above, the following examples relate to this process path


10


′. In these examples, it is assumed that only one pipettor is utilized. Also, whereas the previous examples performed determinations while moving a container


15


along the process lane


28


twice, the process path


10


′ performs determinations while moving a container


15


along the process lane


28


four times. Thus, the second time Process Position


1


is encounter is indicated as


1


′, the third time as


1


″ and the four time as


2


″. However, it is to be noted that more or less movements along the process lane


28


may be employed. Also, the process lane


28


of this embodiment includes 23 Process Positions with Process Position


23


being located adjacent to Process Position


1


.




















Process




Process








Position




Step




Description













 1




Container




Container 15 moved from loading








15 load




lane 30, if present, to process









lane 28 as required







 1




Pipettor




Sample deposited into container









15 by pipetting system







 2




Pipettor




Reagent obtained from reagent









carousel 131 deposited into









container 15







 3




Mixer




Contents of container 15 are









mixed by a device 86 imparting









motion to the container 15







 4-16




Incubation




Contents of container 15 are









incubated at a controlled









temperature, about 37 degrees









Celsius







17




Bypass




Container 15 is selectively








region




positioned at entry to








start




performance lane 62 or avoidance









lane 64 of bypass region







18




Wash




Container 15 in performance lane








zone 1




62 undergoes magnetic separation









and fluid addition







19




Wash




Container 15 in performance lane








zone 1




62 undergoes magnetic separation,









container 15 contents aspiration









and fluid addition







20




Wash




Container 15 in performance lane








zone 1




62 undergoes magnetic separation,









container 15 contents aspiration









and fluid addition







21




Wash




Container 15 in performance lane








zone 1




62 undergoes magnetic separation,









and container 15 contents









aspiration







22




Bypass




Performance and avoidance lanes








region




62 and 64 of bypass region merge








end







23




Process lane




Container 15 selectively








transfer




transferred from process lane 28









to process lane 170







24




Pre-Trigger and




Reagent added to container 15 and








Mixer




mechanically mixed







26-28




Incubation




Contents of container 15 are









incubated at controlled









temperature







29




Shutter,




Indicator reaction (such as








reader,




chemiluminescent reaction)








and




triggered and read with magnetic








trigger




particles pulled out of solution









with magnet. Shutter blocks









light.







30-31




Liquid




Magnetic particles are held at a








Waste




wall of the container 15 and all








Aspirate




liquid in container 15 is









aspirated and discarded







32




Container




Container 15 removed from process








15 unload




lane 28















Given these modifications, it is possible to utilize determination formats that are substantially similar to those discussed previously. For the sake of clarity, those formats, as performed by a process path that performs 50 determinations per hour, are listed below.















Format A














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (18 minutes)




 4-17







Container 15 passes through




18-21







bypass region, first incubation







continues







First incubation continues




22-17″







Separation and wash




18″-21″







Second reagent introduction and




 2′′′-3′′′







mixing







Second incubation (4 minutes)




 4′′′-17′′′







Separation and wash




18′′′-21′′′







Container 15 transferred from




23′′′ of 28







process lane 28 to process lane




to 23 of 170







170







Pretrigger introduction and




24







mixing







Third incubation (1 minute)




25-28







Trigger and read




29







Container 15 evacuate




31







Container 15 removal




32















As an example, Format A may be used to determine at least the following items of interest: antibodies to HCV, antibodies to HIV 1/HIV 2, antibodies to hepatitis B core antigen (HBcAb), carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA19-9), Hepatitis B Surface Antigen (HBsAg), antibodies to Hepatitis B Surface antigen (HBsAb), alpha-fetoprotein (AFP), Total prostate specific antigen (Total PSA), Free PSA, Thyroid stimulating Hormone (TSH), luteinizing hormone (LH), follicle stimulating hormone (FSH), beta human chorionic gonadotropin (B-hCG), Free Thyroxine (Free T4), Free triiodothyronine (Free T3), Total T4, Total T3, Prolactin and Ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format. For instance, this format may also be used to determine beta human chorionic gonadotropin (B-hCG), prolactin and ferritin.















Format B














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (11 minutes)




 4-17′







Separation and wash




18′-21′







Second reagent introduction and




 2″-3″







mixing







Second incubation (11 minutes)




 4″-17′′′







Separation and wash




18′′′-21′′′







Container 15 transferred from




23′′′ of 28







process lane 28 to process lane




to 23 of 170







170







Pretrigger introduction and




25







mixing







Third incubation (1 minute)




26-28







Trigger and read




29







Container 15 evacuate




31







Container 15 removal




32















As an example, Format B may be used to determine an item of interest in a sample where a relatively increased degree of sensitvity, as compared with some other formats, is desired. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.















Format C














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (11 minutes)




 4-17′







Separation and wash




18′-21′







Second reagent introduction and




 2″-3″







mixing







Second incubation (4 minutes)




 4″-17″







Separation and wash




18″-21″







Third reagent introduction and




 2′′′-3′′′







mixing







Third incubation (4 minutes)




 4′′′-17′′′







Separation and wash




18′′′-21′′′







Container 15 transferred from




23′′′ of 28







process lane 28 to process lane




to 23 of 170







170







Pretrigger introduction and




25







mixing







Fourth incubation (1 minute)




26-28







Trigger and read




29







Container 15 evacuate




31







Container 15 removal




32















As an example, Format C may be used when the item of interest relates to hepatitis, such as determinations for anti-M, HBcAb-M and HAVAb-M.















Format D














Step




Position











Sample introduction




 1







First reagent introduction and




 2-3







mixing







First incubation (4 minutes)




 4-17







Transfer to second container 15




24







in position 1







Second reagent introduction and




 2-3







mixing







Second incubation (14 minutes)




 4-17′







Separation and wash




18′-21′







Third reagent introduction and




 2″-3″







mixing







Third incubation (4 minutes)




 4″-17″







Separation and wash




18″-21″







Fourth reagent introduction and




 2′′′-3′′′







mixing







Fourth incubation (4 minutes)




 4′′′-17′′′







Separation and wash




18′′′-21′′′







Container transferred from




23′′′ of 28







process lane 28 to process lane




to 23 of 170







170







Pretrigger introduction and




25







mixing







Fifth incubation (1 minute)




26-28







Trigger and read




29







Container 15 evacuate




31







Container 15 removal




32


























Format E














Step




Position











Sample introduction




 1







First reagent




2-3







introduction and mixing







First incubation (7




 4-17







minutes)







Transfer portion of




24







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




 24-17′







contents continues first







incubation (11 minutes)







Second reagent




2-3







introduction and mixing







with second container 15







contents







First container 15 passes




18″-21″







through bypass region 58B







Second container 15 first




  4-17″







incubation (18 minutes)







Introduction of fourth




2′″-3′″







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal







Second container




18′-21′







separation and wash







Fourth incubation (4




 4′″-17′″







minutes - optional) of







first container 15







Third reagent




24′-25′







introducton into second







container 15 and mixing







First container 15 passes




18′″-21′″







through bypass region







Third incubation (4




 4′″-17′″







minutes) of second







container 15







First container 15




23′″ of 28 to 23 of 170







transferred from process







lane 28 to process lane







170







Pretrigger introduction




25







into first container 15







and mixing







Separation and wash of




18′″-21′″







second container 15







Second container 15




23′″ of 28 to 23 of 170







transferred from process







lane 28 to process lane







170







Trigger and read value 1




29







(Total Hb) from first







container 15







Pretrigger introduction




25







into second container 15







and mixing







Trigger and read value 2




29







(GlyHb)





















Reported





result

=



value





2


value





1


×
100





















For example, in Format E, it is possible to modify the format by disregarding the first container


15


after the portion of the container


15


contents has been transferred (Position


24


) to the second container


15


. In that case, Format E may be used to determine, for example, folate and vitamin B12.















Format F














Step




Position











Sample introduction




1







First reagent




2-3







introduction and mixing







First incubation (7




4-17







minutes)







Transfer portion of




23







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




23-17″







contents continues first







incubation (11 minutes)







Second reagent




2-3







introduction and mixing







with second container 15







contents







First container 15 passes




18″-21″







through bypass region 58B







Second container 15 first




4-17′







incubation (11 minutes)







Introduction of fourth




2′′′-3′″







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




18′-21′







separation and wash







Fourth incubation (4




4′′′-17′″







minutes — optional) of







first container 15







Third reagent




2′′′-3′″







introduction into second







container 15 and mixing







First container 15 passes




18′′′-21′″







through bypass region







Third incubation (11




4′′′-17′″







minutes) of second







container 15







First container 15




23′′′ of 28 to 23 of 170







transferred from process







lane 28 to process lane







170







Pretrigger introduction




25







into first container 15







and mixing







Separation and wash of




18′′′-21′″







second container 15







Trigger and read value 1




29







(Total Hb) from first







container 15







Second container 15




23′′′ of 28 to 23 of 170







transferred from process







lane 28 to process lane







170







Pretrigger introduction




25







into second container 15







and mixing







Trigger and read value 2




29







(GlyHb)





















Reported  result

=



value  2


value  1


×
100





















This format may be used, for example, to determine at least one of total and glycated hemoglobin. Also, this format may be modified by disregarding the first container


15


as in Format E.















Format G














Step




Position











Sample introduction




 1







First reagent




2-3







introduction and mixing







First incubation (6




 4-24







minutes)







Transfer portion of




23







container 15 contents to







second container 15,







remainder of container 15







continues on process lane







28







First container 15




 24-17″







contents continues first







90 incubation (12 minutes)







Second reagent




2-3







introduction and mixing







with second container 15







contents







First container 15




18″-21″







separation and wash







Second container 15 first




4-17″







incubation (18 minutes)







Introduction of fourth




2′″-3′″







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




18″-21″







setaraton and wash







Fourth incubation (4




4′″-17′″







minutes - optional) of







first container 15







Third reagent




2′″-3′″







introduction into second







container 15 and mixing







First container 15




18′″-21′″







separation and wash







Third incubation (4




4′″-17′″







minutes) of second







container 15







First container 15




23′″ of 28 to 23 of 170







transferred from process







lane 28 to process lane







170







Pretrigger introduction




25







into first container 15







and mixing







Separation and wash of




18′″-21′″







second container 15







Second container 15




23′″ of 28 to 23′″ of 170







transferred from process







lane 28 to process lane







170







Trigger and read value 1




29







(Total Hb) from first







container 15







Pretrigger introduction




25







into second container 15







and mixing







Trigger and read value 2




29







(GlyHb)





















Reported





result

=



value





2


value





1


×
100





















As an example, this format may also be modified as may be done with Format F. With that modification, this Format may be used to determine progesterone, testosterone and estradiol.















Format H














Step




Position











Sample introduction




 1







First reagent




 2-3







introduction and mixing







First incubation




 4-17′′′







Separation and wash




18′′′-21′′′







Container 15 transfer




23′′′ of 28







from process lane 28 to




to 23 of 170







process lane 170







Pretrigger introduction




25







and mixing







Second incubation




26-28







Trigger and read




29















As an example, this format may be used to determine, among other things, beta human chorionic gonadotropin (B-hCG), prolactin, progesterone, testosterone, estradiol and ferritin. It is to be noted that almost any item of interest discussed herein may be determined by properly using this format.















Format I














Step




Position











Sample introduction into




 1







first container 15,







possibly with diluent







fluid







First reagent




 2







introduction into first







container 15, portion of







first container 15







contents moved into







pipettor, remainder of







container continues on







process lane 23,







bypassing all wash







stations, to Position 25′







First reagent




2-3







introduction into second







container 15 and mixing







Second container 15 first




 4-17″







incubation (18 minutes)







Introduction of second




2′″-3′″







reagent into first







container 15 and mixing







(optional, enhances total







Hb chemiluminescent







signal)







Second container




18′″-21′″







separation and wash







Fourth incubation (4




 4′″-17′″







minutes - optional) of







first container 15







Third reagent




2′″-3′″







introduction into second







container 15 and mixing







First container 15 passes




13′″-21′″







through bypass region 53







Third incubation (4




 4′″-17′″







minutes) of second







container 15







Pretrigger introduction




25







into first container 15







and mixing







Separation and wash of




18′″-21′″







second container 15







Trigger and read value 1




29







(Total Hb) from first







container 15







Pretrigger introduction




25







into second container 15







and mixing







Trigger and read value 2




29







(GlyHb)





















Reported





result

=



value





2


value





1


×
100





















As an example, in Format I, it is possible to modify the format by disregarding the first container


15


after the portion of the container


15


contents has been transferred (Position


24


) to the second container


15


. In that case, Format I may be used to determine, for example, folate and vitamin B12.















Format J














Step




Position











Sample introduction into




 1







container 15, possibly







with diluent fluid







First reagent




 2-3







introduction and mixing







First incubation (27




 4-47′′′







minutes - four times







along process lane 28)







Pretrigger introduction




25







and mixing







Second incubation (1




26-28







minute)







Trigger and read




29















As an example, Format J may be used to determine, among other things, total hemoglobin.




The embodiments described herein also allow for sample pretreatment which may be performed in at least two ways, indicated as Formats K and L. During performance of sample pretreatment, fluid present in the containers


15


indicated may be processed, after they are no longer significant in the pretreatment steps, in any appropriate manner, such as any of the Formats discussed above. Also, as will become clear later on, both Formats K and L are substantially similarly applicable to the other embodiment of the process path


10


discussed below.















Format K














Step




Position











Sample introduction into




 1







first container 15,







possibly with diluent







fluid







First reagent




 2-3







introduction and mixing







First incubation (6




 4-23







minutes)







Transfer portion of




24







contents of first







container 15 to second







container 15 in position







1







Second reagent




 2-3







introduction to second







container 15 and mixing







(optional)







Transfer portion of




24







contents of second







container 15 to third







container 15 in Position







1







Third reagent




 2-3







introduction to third







container and mixing







(optional)















As an example, the third container


15


may be processed according to at least one of Formats A (to determine, among other things, folate), B, C, H and J.















Format L














Step




Position











Sample introduction into




 1







first container 15,







possibly with diluent







fluid







First reagent




 2-3







introduction and mixing







First incubation (7




 4-23







minutes)







Transfer portion of




24







contents of first







container 15 to second







container 15 in position 1







Second reagent




 2-3







introduction to second







container 15 and mixing







(optional)















As an example, the second container


15


may be processed according to at least one of Formats A (to determine, among other things, folate, vitamin B12, confirm HBsAg), B, C, H and J.




Given commonality among the various embodiments of the process path discussed and exemplified above, it is to be appreciated that assay formats performed on each of the various embodiments are essentially the same. The time frames are identical. Reagents for a particular assay used on one of the embodiments may also be used on other embodiments.




Upon consideration of all of these examples and their common features, it is to be understood that the process path


10


, or in other words the process lane


28


, has a variable physical length. However, the effective length of the process path


10


is constant in all embodiments. This effective length represents the total distance traveled by the container


15


along the process path


10


during performance of a certain determination. The physical length, i.e. the physical dimensions of the process path


10


, is variable, for instance, to make the process path


10


fit within a given space. The effective length of the process path


10


is maintained constant by moving the container


15


multiple times along the same process path


10


(4 times in the last set of examples). Maintenance of the effective length is achieved with appropriate combination of selective automatic performance of a given determination process step. In all instances, the effective length remains constant even though the physical length of a given process path


10


may be longer or shorter than other process paths


10


.




It is to be noted that all of the above discussed embodiments of the process path


10


include and utilize certain common elements, such as reagents, a sample/reagent pipettor, a mixer, a wash zone and a reader. The structural elements are arranged along each embodiment of the process path


10


such that each embodiment is able to perform the same determinations in substantially the same manner by keeping the effective length of the process path


10


constant. Each of the embodiments of the process path executes determinations with approximately the same number, such as 98 in the above examples, “steps” of the container


15


along the process path


10


between sample introduction and reading. Determination of a given item of interest by one of the embodiments of the process path


10


takes substantially the same amount of time as a determination of the same item or interest by another embodiment of the process path


10


. Thus, it is possible to construct a structure for performing item of interest determinations which conforms to desired physical dimensions, throughput requirements, etc., while using the common elements discussed herein by maintaining the effective length of the process path constant.



Claims
  • 1. A structure for performing a process for determining an item of interest in a sample, the structure comprising:(a) a process path, the process path comprising: (i) a process lane in which a reaction container is moved, the process lane diverging into (ii) a process step performance lane where a process step of a process for determining the item of interest in the sample is performed, and (iii) a process step avoidance lane where no process step of the process for determining the item of interest in the sample is performed, the process step performance lane and the process step avoidance lane being disposed substantially side by side, both the process step performance lane and the process step avoidance lane converging to the process lane; (b) a first prime mover operatively connected with the process path for moving the reaction container along the process lane, said first prime mover, by itself, being (i) capable of moving the reaction container so as to enable the reaction container to simultaneously pass through the process step performance lane and along side of the process step avoidance lane and being (ii) capable of moving the reaction container so as to enable the reaction container to simultaneously pass along side of the process step performance lane and through the process step avoidance lane; (c) a first pipetting system operatively associated with the process step performance lane for introducing the sample to the reaction container moved along the process lane; (d) a second pipetting system operatively associated with the process step performance lane for introducing a reagent to the reaction container moved along the process lane; (e) a device operatively connected with the process step performance lane and selectively engagable with the reaction container for mixing the sample and the reagent in the reaction container moved along the process lane; (f) a second prime mover operatively connected with the process path for selectively positioning the reaction container in the process step performance lane or the process step avoidance lane; and (g) a reader operatively connected with the process step performance lane for determining the item of interest in the sample based upon a reaction between the sample and the reagent contained within the reaction container.
  • 2. A structure as defined in claim 1 wherein the process path further comprises:(iv) a cover; (v) a base connected with the cover; and (vi) a disk rotatably disposed between the cover and the base.
  • 3. A structure as defined in claim 2 further comprising a drain duct disposed on at least one of the cover or the base for facilitating removal of fluid from the process path.
  • 4. A structure as defined in claim 2 further comprising a slot disposed on the disk for accepting the reaction container.
  • 5. A structure as defined in claim 4 wherein the slot has a longitudinal axis and wherein the reaction container is movable within the slot along the longitudinal axis.
  • 6. A structure as defined in claim 5 further comprising a third prime mover operatively connected with the process path and engagable with the reaction container for moving the reaction container along the longitudinal axis.
  • 7. A structure as defined in claim 5 wherein the process path further comprises:(iv) means for moving the reaction container along the longitudinal axis.
  • 8. A structure as defined in claim 4 wherein the slot has a latitudinally expanded width to facilitate removal of the reaction container from the slot.
  • 9. A structure as defined in claim 1 wherein the process path further comprises:(iv) a loading lane for accepting the reaction container from a reaction container supply, the loading lane being operatively connected with the process lane so that the reaction container can move between the loading lane and the process lane.
  • 10. A structure as defined in claim 9 wherein the process path further comprises:(v) a passageway operatively connecting the loading lane and the process lane for allowing the reaction container to move from the loading lane to the process lane.
  • 11. A structure as defined in claim 10 further comprising:(h) a third prime mover operatively connected with the process path for moving the reaction container through the passageway.
  • 12. A structure as defined in claim 1 further comprising:(h) a magnet connected with the process path such that the reaction container moved along the process lane encounters the magnet.
  • 13. A structure as defined in claim 1 further comprising:(h) a carousel disposed adjacent the process path for supplying the reagent to the second pipetting system.
  • 14. A structure as defined in claim 1 further comprising:(h) a wash station operatively connected with the process path for washing the reaction cuvette moved along the process lane.
  • 15. A structure for performing a process for determining an item of interest in a sample, the structure comprising:(a) a process path, the process path comprising: (i) a process lane accepting a reaction container, the process lane diverging into (ii) a process step performance lane where a process step of a process for determining the item of interest in the sample is performed, and (iii) a process step avoidance lane where no process step of the process for determining the item of interest in the sample is performed, the process step performance lane and the process step avoidance lane being disposed substantially side by side, both the process step performance lane and the process step avoidance lane converging to the process lane; (iv) a cover; (v) a base connected with the cover; and (vi) a disk rotatably disposed between the cover and the base, said structure further including, a first prime mover that, by itself, is (i) capable of moving the reaction container so as to enable the reaction container to simultaneously pass through the process step performance lane and along side of the process step avoidance lane and is (ii) capable of moving the reaction container so as to enable the reaction container to simultaneously pass along side of the process step performance lane and through the process step avoidance lane.
  • 16. A structure as defined in claim 15 further comprising:(b) a prime mover operatively connected with the process path for selectively positioning the reaction container on the process step performance lane or the process step avoidance lane.
  • 17. A structure as defined in claim 15 further comprising a drain duct disposed on at least one of the cover or the base for facilitating removal of fluid from the process path.
  • 18. A structure as defined in claim 17 wherein the disk rotates in a first direction and the drain duct is oriented in the first direction to facilitate removal of fluid from the structure.
  • 19. A structure as defined in claim 15 wherein the process path further comprises a belt movably disposed between the cover and the base, and the process lane is formed on at least one of the cover and the base.
REFERENCE TO RELATED APPLICATION

This case is a divisional application of U.S. patent application, Ser. No. 09/140,607, filed on Aug. 26, 1998, which is a divisional of Ser. No. 08/715,780, now U.S. Pat. No. 5,856,194 filed on Sep. 19, 1996, both of which are assigned to the assignee of the present case.

US Referenced Citations (781)
Number Name Date Kind
893469 Essmuller Jul 1908 A
1180665 McElroy Apr 1916 A
2587221 Richardson et al. Feb 1952 A
2837092 Scholler et al. Jun 1958 A
2906423 Sandhage Sep 1959 A
2948940 Degener Aug 1960 A
2955722 Antonious Oct 1960 A
3019932 Singiser Feb 1962 A
3038340 Isreeli Jun 1962 A
3085705 Varney Apr 1963 A
3107537 Isreeli et al. Oct 1963 A
3178266 Anthon Apr 1965 A
3190731 Weiskoff Jun 1965 A
3192968 Baruch et al. Jul 1965 A
3193358 Baruch Jul 1965 A
3223269 Williams Dec 1965 A
3272240 Roth Sep 1966 A
3302772 Alsop Feb 1967 A
3307371 Andros Mar 1967 A
3317069 Chin May 1967 A
3399116 Du Bois et al. Aug 1968 A
3457048 Stephens et al. Jul 1969 A
3489521 Buckle et al. Jan 1970 A
3489525 Natelson Jan 1970 A
3533744 Unger Oct 1970 A
3555143 Axen et al. Jan 1971 A
3578291 Oberil May 1971 A
3594129 Jones Jul 1971 A
3606074 Hayes Sep 1971 A
3607094 Beer Sep 1971 A
3607098 Strande Sep 1971 A
3609040 Kuzel et al. Sep 1971 A
3614434 Horwitz et al. Oct 1971 A
3615230 Barnick et al. Oct 1971 A
3616264 Ray et al. Oct 1971 A
3617222 Matte Nov 1971 A
3621203 Geominy et al. Nov 1971 A
3633768 Gulgen Jan 1972 A
3634651 Siegel Jan 1972 A
3635094 Oberli Jan 1972 A
3638507 Orner Feb 1972 A
3643812 Mander et al. Feb 1972 A
3644095 Netheler et al. Feb 1972 A
3652761 Woetail Mar 1972 A
3653528 Wimmer Apr 1972 A
3654090 Wilhelmus Apr 1972 A
3655089 Tower Apr 1972 A
3658478 Spergel et al. Apr 1972 A
3673886 Tomita et al. Jul 1972 A
3676080 Richterich Jul 1972 A
3676679 Waters Jul 1972 A
3687632 Natelson Aug 1972 A
3702612 Schlesinger Nov 1972 A
3708264 Jottier Jan 1973 A
3720116 Better et al. Mar 1973 A
3722312 Better et al. Mar 1973 A
3723066 Moran Mar 1973 A
3727029 Chrow Apr 1973 A
3728079 Moran Apr 1973 A
3746514 Colvin et al. Jul 1973 A
3753657 Downing et al. Aug 1973 A
3764268 Kosowsky et al. Oct 1973 A
3765237 Blackmer et al. Oct 1973 A
3767364 Ritchie et al. Oct 1973 A
3770382 Carter et al. Nov 1973 A
3784785 Noland Jan 1974 A
3790346 Ritchie Feb 1974 A
3791537 Conklin Feb 1974 A
3796544 Zauft et al. Mar 1974 A
3806321 Durrum et al. Apr 1974 A
3807457 Logsdon Apr 1974 A
3807955 Note, Jr. et al. Apr 1974 A
3811842 Diebler et al. May 1974 A
3813215 Ward May 1974 A
3823840 Zackheim Jul 1974 A
3826397 Atkins Jul 1974 A
3826621 Johnson, Jr. et al. Jul 1974 A
3830108 Spong Aug 1974 A
3843323 Quame Oct 1974 A
3850174 Ayres Nov 1974 A
3850341 Bart Nov 1974 A
3850580 Moore et al. Nov 1974 A
3851541 Ploss et al. Dec 1974 A
3854879 Figueroa et al. Dec 1974 A
3868493 Caroleo Feb 1975 A
3883305 Hoskins et al. May 1975 A
3883306 Widen May 1975 A
3894706 Mizusawa Jul 1975 A
3897216 Jones Jul 1975 A
3900289 Liston Aug 1975 A
3912456 Young Oct 1975 A
3917455 Bak et al. Nov 1975 A
3933997 Hersh et al. Jan 1976 A
3948607 Atwood et al. Apr 1976 A
3949189 Bilbro et al. Apr 1976 A
3951605 Natelson Apr 1976 A
3970518 Giaever Jul 1976 A
3977551 Ciarico Aug 1976 A
3980268 Ellis Sep 1976 A
3981776 Saxholm Sep 1976 A
3985508 Williams Oct 1976 A
4000252 Kosak Dec 1976 A
4000973 Petesen Jan 1977 A
4000974 Acord Jan 1977 A
4002532 Weltman et al. Jan 1977 A
4004883 Meyer et al. Jan 1977 A
RE29169 Schuurs et al. Apr 1977 E
4016043 Schuurs et al. Apr 1977 A
4018886 Giaever Apr 1977 A
4022579 Revillet et al. May 1977 A
4034071 Strickler Jul 1977 A
4039287 Moran Aug 1977 A
4039652 Adams et al. Aug 1977 A
4040533 De Boer et al. Aug 1977 A
4041146 Giaever Aug 1977 A
4045179 Bunce Aug 1977 A
4046248 Goffredo et al. Sep 1977 A
4047034 Auphan Sep 1977 A
4054416 Duff Oct 1977 A
4058367 Gilford Nov 1977 A
4065358 Kawai et al. Dec 1977 A
4066412 Johnson et al. Jan 1978 A
4067694 Blakely et al. Jan 1978 A
4077444 Gilson et al. Mar 1978 A
4077804 Vanzo Mar 1978 A
4078971 Arkles et al. Mar 1978 A
4080833 Huber Mar 1978 A
4081245 Polito Mar 1978 A
4081246 Polito et al. Mar 1978 A
4094641 Friswell Jun 1978 A
4098876 Plasie et al. Jul 1978 A
4104029 Maier, Jr. Aug 1978 A
4106907 Charlton et al. Aug 1978 A
4108972 Dreyer Aug 1978 A
4112517 Giombini Sep 1978 A
4113383 Burns et al. Sep 1978 A
4113436 Werder et al. Sep 1978 A
4115534 Ithakissios Sep 1978 A
4115535 Giaever Sep 1978 A
4115861 Allington Sep 1978 A
4118280 Charles et al. Oct 1978 A
4118801 Kraft et al. Oct 1978 A
4119709 Holub Oct 1978 A
4120662 Fosslien Oct 1978 A
4123121 Ernst et al. Oct 1978 A
4125492 Cuatrecasas et al. Nov 1978 A
4131788 Fulbrook Dec 1978 A
RE29880 Duff Jan 1979 E
4133873 Noller Jan 1979 A
4134512 Nugent Jan 1979 A
4137216 Lemper et al. Jan 1979 A
4139242 Ernst Feb 1979 A
4139604 Gutcho et al. Feb 1979 A
4140020 Cook Feb 1979 A
4141524 Corvese, Jr. Feb 1979 A
4141687 Forrest et al. Feb 1979 A
4147250 Schulz Apr 1979 A
4151931 Scherer et al. May 1979 A
4152210 Robinson et al. May 1979 A
4152269 Babson May 1979 A
4152577 Leavines May 1979 A
4155978 Naono et al. May 1979 A
4157323 Yen et al. Jun 1979 A
4160165 McCombs et al. Jul 1979 A
4166095 Kling et al. Aug 1979 A
4166104 Wagner et al. Aug 1979 A
4168955 Allington Sep 1979 A
4169138 Jonsson Sep 1979 A
4169804 Yapel et al. Oct 1979 A
4177253 Davies et al. Dec 1979 A
4185084 Mochida et al. Jan 1980 A
4187075 Noller Feb 1980 A
4191287 Brook et al. Mar 1980 A
4192845 Kalasek Mar 1980 A
4193866 Slusarczuk et al. Mar 1980 A
4200436 Mochida et al. Apr 1980 A
4202634 Kraft et al. May 1980 A
4205885 Ernst et al. Jun 1980 A
4206094 Yen et al. Jun 1980 A
4206951 Ernst et al. Jun 1980 A
4207289 Weiss Jun 1980 A
4208484 Sogi et al. Jun 1980 A
4213999 Witiak et al. Jul 1980 A
4218539 Weltman Aug 1980 A
4228237 Hevey et al. Oct 1980 A
4229104 Lahme et al. Oct 1980 A
4230685 Senyei et al. Oct 1980 A
4230797 Bogulaski et al. Oct 1980 A
4231750 Dowben et al. Nov 1980 A
4232119 Carlsson et al. Nov 1980 A
4234538 Ginsberg et al. Nov 1980 A
4234540 Ginsberg et al. Nov 1980 A
4235869 Schwarzberg Nov 1980 A
4235960 Sasse et al. Nov 1980 A
4238195 Boguslaski et al. Dec 1980 A
4239298 Ernst et al. Dec 1980 A
4241176 Avrameas et al. Dec 1980 A
4244459 Garrett Jan 1981 A
4244920 Manschot et al. Jan 1981 A
4250400 Lee Feb 1981 A
4254460 Achter et al. Mar 1981 A
4256106 Shoor Mar 1981 A
4256725 Rutner et al. Mar 1981 A
4256960 Snider Mar 1981 A
4257884 Lim Mar 1981 A
4259288 Welch Mar 1981 A
4259289 Curry et al. Mar 1981 A
4259291 Smythe Mar 1981 A
4261893 Boguslaski et al. Apr 1981 A
RE30627 Bagshawe et al. May 1981 E
4265855 Mandle et al. May 1981 A
4266651 Strom May 1981 A
4267149 Bruckner et al. May 1981 A
4267234 Rembaum May 1981 A
4267235 Rembaum May 1981 A
4268477 Herzstark May 1981 A
4272482 Jessop et al. Jun 1981 A
4272506 Schwarzberg Jun 1981 A
4272510 Smith et al. Jun 1981 A
4276051 Ginsberg et al. Jun 1981 A
4276258 Ginsberg et al. Jun 1981 A
4277440 Jessop et al. Jul 1981 A
4278437 Haggar Jul 1981 A
4279992 Boguslaski et al. Jul 1981 A
4281387 Kraft et al. Jul 1981 A
RE30730 Duff Sep 1981 E
4292920 Smith et al. Oct 1981 A
4294078 Percarpio et al. Oct 1981 A
4294799 Stephens et al. Oct 1981 A
4295572 Percarpio Oct 1981 A
4297337 Mansfield et al. Oct 1981 A
4298593 Ling Nov 1981 A
4298687 Maes Nov 1981 A
4302534 Halmann et al. Nov 1981 A
4305668 Bilbrey Dec 1981 A
4305924 Piasio et al. Dec 1981 A
4307766 Tanokura Dec 1981 A
4311348 Olschewski et al. Jan 1982 A
4311667 Gocho Jan 1982 A
4312835 Zoltan et al. Jan 1982 A
4313734 Leuvering Feb 1982 A
4313735 Yamashita et al. Feb 1982 A
4315891 Sakurada Feb 1982 A
4315907 Fridlender et al. Feb 1982 A
4318707 Litman et al. Mar 1982 A
4318884 Suzuki Mar 1982 A
4318980 Boguslaski et al. Mar 1982 A
4320109 Wolf et al. Mar 1982 A
4322216 Lillig et al. Mar 1982 A
4325909 Coulter et al. Apr 1982 A
4325910 Jordan Apr 1982 A
4330299 Cerami May 1982 A
4332471 Gross Jun 1982 A
4332783 Pernice et al. Jun 1982 A
4333356 Bartels et al. Jun 1982 A
4335620 Adams Jun 1982 A
4335730 Griffin Jun 1982 A
4341736 Drbal et al. Jul 1982 A
4343766 Sisti et al. Aug 1982 A
4343901 DeFilippi Aug 1982 A
4345843 Berglund et al. Aug 1982 A
4346056 Sakurada Aug 1982 A
4346742 Chase et al. Aug 1982 A
4349510 Kolehmainen et al. Sep 1982 A
4351800 Kopp et al. Sep 1982 A
4355165 Boguslaski et al. Oct 1982 A
4356722 Bunce et al. Nov 1982 A
4356967 Lunick Nov 1982 A
4357301 Cassaday et al. Nov 1982 A
4362531 de Steenwinkel et al. Dec 1982 A
4363759 Boguslaski et al. Dec 1982 A
4363781 Akamatsu et al. Dec 1982 A
4366118 Bunce et al. Dec 1982 A
4366119 Takeuchi Dec 1982 A
4369226 Rembaum Jan 1983 A
4372745 Mandle et al. Feb 1983 A
4373925 Litman et al. Feb 1983 A
4373931 Takekawa Feb 1983 A
4376110 David et al. Mar 1983 A
4380580 Boguslaski et al. Apr 1983 A
4383031 Boguslaski et al. May 1983 A
4385126 Chen et al. May 1983 A
4397385 Booth et al. Aug 1983 A
4402909 Solazzi Sep 1983 A
4403040 Van Aken Sep 1983 A
4407943 Cole et al. Oct 1983 A
4407964 Elings et al. Oct 1983 A
4414324 Stout Nov 1983 A
4415700 Batz et al. Nov 1983 A
4418846 Pong et al. Dec 1983 A
4419734 Wolfson et al. Dec 1983 A
4421860 Elings et al. Dec 1983 A
4433059 Chang et al. Feb 1984 A
4433060 Frenzel Feb 1984 A
4435509 Berthold et al. Mar 1984 A
4437762 Glenn et al. Mar 1984 A
4438068 Forrest Mar 1984 A
4438986 Teramachi Mar 1984 A
4451433 Yamashita et al. May 1984 A
4454226 Ali et al. Jun 1984 A
4454234 Czerlinski Jun 1984 A
4454939 Kampf et al. Jun 1984 A
4455280 Shinohara et al. Jun 1984 A
4456037 Gocho Jun 1984 A
4459265 Berglund Jul 1984 A
4459359 Neurath Jul 1984 A
4472352 Quesneau et al. Sep 1984 A
4477576 Deutsch et al. Oct 1984 A
4477578 Miles et al. Oct 1984 A
4478817 Campbell et al. Oct 1984 A
4482636 Mochida et al. Nov 1984 A
4483823 Umetsu et al. Nov 1984 A
4483927 Takekawa Nov 1984 A
4484061 Zelinka et al. Nov 1984 A
4484815 Akiyama Nov 1984 A
4488633 Kampf Dec 1984 A
4491634 Frenzel Jan 1985 A
4492751 Boguslaski et al. Jan 1985 A
4495295 Neurath Jan 1985 A
4495296 Neurath et al. Jan 1985 A
4497774 Scordato Feb 1985 A
D278182 Aihara et al. Mar 1985 S
4504585 Reynolds Mar 1985 A
4506009 Lenhoff et al. Mar 1985 A
4506777 Kampf Mar 1985 A
4515752 Miramanda May 1985 A
4517160 Galle et al. May 1985 A
4517288 Giegel et al. May 1985 A
4517460 Meulenbrugge et al. May 1985 A
4517851 Tice May 1985 A
4522921 Ogawa Jun 1985 A
4523295 Zato Jun 1985 A
4523862 Yasui et al. Jun 1985 A
4523864 Walter et al. Jun 1985 A
4528159 Liston Jul 1985 A
4533255 Gronholz et al. Aug 1985 A
4533629 Litman et al. Aug 1985 A
4534465 Rothermel et al. Aug 1985 A
4536369 Sakurada et al. Aug 1985 A
4537510 Takahasi Aug 1985 A
4537861 Elings et al. Aug 1985 A
4540660 Harte et al. Sep 1985 A
4541291 Churchill et al. Sep 1985 A
4542661 Teramachi Sep 1985 A
4542833 DeVaughn Sep 1985 A
4545497 Martha, Jr. Oct 1985 A
4551426 Freytag et al. Nov 1985 A
4551619 Lefebvre Nov 1985 A
4552812 Margel et al. Nov 1985 A
4552839 Gould et al. Nov 1985 A
4554088 Whitehead et al. Nov 1985 A
4555183 Thomas Nov 1985 A
4559120 Royse et al. Dec 1985 A
4560269 Baldszun et al. Dec 1985 A
4561820 Matheny, III et al. Dec 1985 A
4576912 Yaverbaum et al. Mar 1986 A
4578244 Cosgrove, Jr. et al. Mar 1986 A
4581521 Grise Apr 1986 A
4583668 Maynard, Jr. Apr 1986 A
4584277 Ullman Apr 1986 A
D283728 Aihara May 1986 S
4588697 Khanna et al. May 1986 A
4595562 Liston et al. Jun 1986 A
4604348 Neurath Aug 1986 A
4610546 Intraub Sep 1986 A
4613567 Yasoshima et al. Sep 1986 A
4615360 Jacobs Oct 1986 A
4623621 Pestka Nov 1986 A
4623629 Kerschensteiner Nov 1986 A
4628037 Chagnon et al. Dec 1986 A
4629688 Bolguslaski et al. Dec 1986 A
4629690 Weng et al. Dec 1986 A
4629703 Uffenheimer Dec 1986 A
4634575 Kawakami et al. Jan 1987 A
4634576 Galle et al. Jan 1987 A
4637985 Sidki et al. Jan 1987 A
4639135 Borer et al. Jan 1987 A
4639425 Baier Jan 1987 A
4639875 Abraham et al. Jan 1987 A
4643879 Hanaway Feb 1987 A
4645646 Gadow et al. Feb 1987 A
4645747 Cais et al. Feb 1987 A
D288845 Borer et al. Mar 1987 S
4647432 Wakatake Mar 1987 A
4649116 Daty et al. Mar 1987 A
4651813 Witt et al. Mar 1987 A
4652519 Warshawsky et al. Mar 1987 A
4652533 Jolley Mar 1987 A
4654299 Lentfer Mar 1987 A
4654300 Zuk et al. Mar 1987 A
4657851 Feller et al. Apr 1987 A
4659678 Forrest et al. Apr 1987 A
4661444 Li Apr 1987 A
4661498 Lau et al. Apr 1987 A
4663277 Wang May 1987 A
4666866 Krauth May 1987 A
4668617 Furuta et al. May 1987 A
4670219 Nelson et al. Jun 1987 A
4670381 Frickey et al. Jun 1987 A
4670383 Baier et al. Jun 1987 A
4672040 Josephson Jun 1987 A
4676656 Cook et al. Jun 1987 A
4676951 Armes et al. Jun 1987 A
4678752 Thorne et al. Jul 1987 A
4680275 Wagner et al. Jul 1987 A
4681741 Hanaway Jul 1987 A
4687638 Benajam Aug 1987 A
4689305 Stiffey et al. Aug 1987 A
4693969 Saxena et al. Sep 1987 A
4693970 O'Connell et al. Sep 1987 A
4695392 Whitehead et al. Sep 1987 A
4695393 Whitehead et al. Sep 1987 A
4698302 Whitehead et al. Oct 1987 A
4699797 Aihara Oct 1987 A
4706736 Gyori Nov 1987 A
4708886 Nelson Nov 1987 A
4710472 Saur et al. Dec 1987 A
4711839 Singhal Dec 1987 A
4713974 Stone Dec 1987 A
4731225 Wakatake Mar 1988 A
4731337 Luotola et al. Mar 1988 A
4732811 Margel Mar 1988 A
4737342 Herrmann et al. Apr 1988 A
4737453 Primus Apr 1988 A
4738825 Kelln Apr 1988 A
4740457 Parratt Apr 1988 A
4743536 Evanega et al. May 1988 A
4743544 Namba et al. May 1988 A
4743560 Campbell et al. May 1988 A
4745077 Holian et al. May 1988 A
4747693 Kahl May 1988 A
4753775 Ebersole et al. Jun 1988 A
4754414 Gocho Jun 1988 A
4755055 Johnson et al. Jul 1988 A
4755356 Robbins et al. Jul 1988 A
4758523 Harjunmaa Jul 1988 A
4761268 Andersen et al. Aug 1988 A
4761379 Williams et al. Aug 1988 A
4763803 Schneider Aug 1988 A
4764342 Kelln et al. Aug 1988 A
4771429 Davis et al. Sep 1988 A
4772453 Lisenbee Sep 1988 A
4772550 Greenquist Sep 1988 A
4774055 Wakatake et al. Sep 1988 A
4774174 Giegel et al. Sep 1988 A
4774191 Khanna et al. Sep 1988 A
4775635 Ebersole et al. Oct 1988 A
4775636 Moeremans et al. Oct 1988 A
4777145 Luotola et al. Oct 1988 A
4778763 Makiguchi et al. Oct 1988 A
4778767 Hummelen et al. Oct 1988 A
4780421 Kameda et al. Oct 1988 A
4781891 Galle et al. Nov 1988 A
4783336 Margel et al. Nov 1988 A
4783835 Satoh Nov 1988 A
4784213 Eager et al. Nov 1988 A
4785953 Buchholz et al. Nov 1988 A
4786606 Giegel et al. Nov 1988 A
4788136 Grenier et al. Nov 1988 A
4788150 Nelson et al. Nov 1988 A
4791055 Boguslaski et al. Dec 1988 A
4791056 Sizto et al. Dec 1988 A
4793973 Ringrose Dec 1988 A
4798095 Itoh Jan 1989 A
4799599 Herrmann Jan 1989 A
4806313 Ebersole et al. Feb 1989 A
4808380 Minekane Feb 1989 A
4808522 Atabekov et al. Feb 1989 A
4816418 Mack et al. Mar 1989 A
4820497 Howell Apr 1989 A
4824778 Nagai et al. Apr 1989 A
4827780 Sarrine et al. May 1989 A
4830832 Arpagauset et al. May 1989 A
4837159 Yamada Jun 1989 A
4837395 Leeder et al. Jun 1989 A
4842827 Graf et al. Jun 1989 A
4843000 Litman et al. Jun 1989 A
4843001 Haug et al. Jun 1989 A
4843010 Nawinski et al. Jun 1989 A
4845025 Lary et al. Jul 1989 A
4848917 Benin et al. Jul 1989 A
4849176 Sakagami Jul 1989 A
4849338 Litman et al. Jul 1989 A
4850470 Ferkany Jul 1989 A
4852967 Cook et al. Aug 1989 A
4855110 Marker et al. Aug 1989 A
4855242 Soeldner Aug 1989 A
4859423 Perlman Aug 1989 A
4859583 Heller et al. Aug 1989 A
4861553 Mawhirt et al. Aug 1989 A
4861554 Sakuma Aug 1989 A
4863690 Berthold et al. Sep 1989 A
4863875 Bailey et al. Sep 1989 A
4868130 Hargreaves Sep 1989 A
4868131 Hiratsuka Sep 1989 A
4871683 Harris et al. Oct 1989 A
4886177 Foster Dec 1989 A
4890930 Nohso Jan 1990 A
4891311 Anawis et al. Jan 1990 A
4895453 Devlin et al. Jan 1990 A
4895650 Wang Jan 1990 A
4900513 Barker et al. Feb 1990 A
4900686 Arnost et al. Feb 1990 A
4904583 Mapes et al. Feb 1990 A
4904632 Pesek et al. Feb 1990 A
4906432 Geiselman Mar 1990 A
4906433 Minekane Mar 1990 A
4908186 Sakamaki Mar 1990 A
4910148 Sorensen et al. Mar 1990 A
4911230 Mayer et al. Mar 1990 A
4916080 Imai et al. Apr 1990 A
4916081 Kamada et al. Apr 1990 A
4919887 Wakatake Apr 1990 A
4927545 Roginski May 1990 A
4927605 Dom et al. May 1990 A
4927769 Chang et al. May 1990 A
4928539 Champecix May 1990 A
4931385 Block et al. Jun 1990 A
4931402 Abplanalp Jun 1990 A
4933146 Meyer et al. Jun 1990 A
4933276 Baret Jun 1990 A
4935339 Zahradnik Jun 1990 A
4937048 Sakai et al. Jun 1990 A
D309080 Buchholz Jul 1990 S
4939946 Teramschi Jul 1990 A
4941201 Davis Jul 1990 A
4941809 Pinkerton Jul 1990 A
4942017 Turpen Jul 1990 A
4943164 Ohishi et al. Jul 1990 A
4944924 Mawhirt et al. Jul 1990 A
4946651 Liston et al. Aug 1990 A
4948726 Longoria Aug 1990 A
4950588 Dattagupta Aug 1990 A
4951512 Mazza et al. Aug 1990 A
4952707 Edwards et al. Aug 1990 A
4953075 Nan et al. Aug 1990 A
4954149 Fullemann Sep 1990 A
4954319 Koizumi et al. Sep 1990 A
4954452 Yost et al. Sep 1990 A
4954882 Kamemoto Sep 1990 A
4959303 Milburn et al. Sep 1990 A
4961906 Andersen et al. Oct 1990 A
4962023 Todd et al. Oct 1990 A
4965049 Lillig et al. Oct 1990 A
4965187 Tonelli Oct 1990 A
4966839 Kaspar Oct 1990 A
4967159 Manes Oct 1990 A
4969565 Justai et al. Nov 1990 A
4977786 Davis Dec 1990 A
4978625 Wagner et al. Dec 1990 A
4980293 Jeffs Dec 1990 A
4984628 Uchida et al. Jan 1991 A
4986891 Sarrine et al. Jan 1991 A
4988618 Li et al. Jan 1991 A
4989822 Fannon Feb 1991 A
4992377 Saxholm Feb 1991 A
4997768 Uffenheimer et al. Mar 1991 A
5004582 Miyata et al. Apr 1991 A
5004904 Yamakawa et al. Apr 1991 A
5008082 Shaw Apr 1991 A
5009942 Benin et al. Apr 1991 A
5009998 Chow et al. Apr 1991 A
5015157 Pinkerton et al. May 1991 A
5017790 Kojima May 1991 A
4906432 Geiselman Jun 1991 A
5020980 Pinkerton Jun 1991 A
5024256 Vadher Jun 1991 A
5030418 Miyata Jul 1991 A
5037612 Takahashi et al. Aug 1991 A
5038958 Dreier Aug 1991 A
5039860 Yrjonen et al. Aug 1991 A
5043141 Wilson et al. Aug 1991 A
5043143 Shaw et al. Aug 1991 A
5044889 Pinkerton Sep 1991 A
5047210 Melet Sep 1991 A
5055262 Sakagami Oct 1991 A
5057281 Torti et al. Oct 1991 A
5061448 Mahe et al. Oct 1991 A
5061630 Knopf et al. Oct 1991 A
5066135 Meyer et al. Nov 1991 A
5066844 Schuster et al. Nov 1991 A
5068088 Hall et al. Nov 1991 A
5071625 Kelln et al. Dec 1991 A
5071766 Barr et al. Dec 1991 A
5073625 Derbyshire Dec 1991 A
5077013 Guigan Dec 1991 A
5077488 Davis Dec 1991 A
5079424 Kobayashi Jan 1992 A
5081872 Greter Jan 1992 A
5082628 Andreotti et al. Jan 1992 A
5084242 Sakuma et al. Jan 1992 A
5086215 Carsner et al. Feb 1992 A
5086233 Stafford et al. Feb 1992 A
5087423 Ishibashi Feb 1992 A
5089418 Shaw et al. Feb 1992 A
5091206 Wang et al. Feb 1992 A
5096670 Harris et al. Mar 1992 A
5098660 Devaney, Jr. Mar 1992 A
5098661 Froehlich et al. Mar 1992 A
5098663 Berthold et al. Mar 1992 A
5102631 Jordan et al. Apr 1992 A
5104231 Collier et al. Apr 1992 A
5104621 Pfost et al. Apr 1992 A
5104807 mitsumaki et al. Apr 1992 A
5104808 Laska et al. Apr 1992 A
5108175 Whitlock Apr 1992 A
5108703 Pfost et al. Apr 1992 A
5108928 Menard et al. Apr 1992 A
5112646 Koshi et al. May 1992 A
5122343 Ishizaka et al. Jun 1992 A
5123477 Tyler Jun 1992 A
5127541 Wakatake Jul 1992 A
5128103 Wang et al. Jul 1992 A
5128105 Berthold et al. Jul 1992 A
5130254 Collier et al. Jul 1992 A
5133936 Umetsu et al. Jul 1992 A
5137693 Mawhirt Aug 1992 A
5139743 Ishizaka et al. Aug 1992 A
5139744 Kowalski Aug 1992 A
5139951 Butz et al. Aug 1992 A
5143236 Gueret Sep 1992 A
5145784 Cox et al. Sep 1992 A
5147529 Lee et al. Sep 1992 A
D330428 Lewis et al. Oct 1992 S
5158895 Ashihara et al. Oct 1992 A
5162236 Pang et al. Nov 1992 A
5163360 Petz Nov 1992 A
5163582 Godolphin et al. Nov 1992 A
5164318 Sato et al. Nov 1992 A
5167929 Korf et al. Dec 1992 A
5171979 Kwa et al. Dec 1992 A
5174960 Shaw et al. Dec 1992 A
5175086 Takekawa et al. Dec 1992 A
5176203 Larzul Jan 1993 A
5178019 Keiter Jan 1993 A
5178479 Brown et al. Jan 1993 A
5178834 Kagayama et al. Jan 1993 A
5180555 Monget Jan 1993 A
5183638 Wakatake Feb 1993 A
5186339 Heissler Feb 1993 A
5186827 Liberti et al. Feb 1993 A
5187084 Hallsby Feb 1993 A
5200084 Liberti et al. Apr 1993 A
5200151 Long Apr 1993 A
5200975 Kato Apr 1993 A
5202093 Cloyd Apr 1993 A
5206171 Dillon et al. Apr 1993 A
5207986 Kadota et al. May 1993 A
5209903 Kanamori et al. May 1993 A
5212094 Ogawa May 1993 A
5213761 Sakagami May 1993 A
5215376 Schulte et al. Jun 1993 A
5215714 Okada et al. Jun 1993 A
5216926 Lipscomb Jun 1993 A
5223218 Fukuoka et al. Jun 1993 A
5225165 Perlman Jul 1993 A
5229074 Heath et al. Jul 1993 A
5232664 Krawzak et al. Aug 1993 A
5232665 Burkovich Aug 1993 A
5236666 Hulette Aug 1993 A
5236824 Fujiwara et al. Aug 1993 A
5238810 Fujiwara et al. Aug 1993 A
5240674 Armor Aug 1993 A
5240679 Stettler Aug 1993 A
5242659 Wurschum Sep 1993 A
5242660 Hsei Sep 1993 A
5244633 Jakubowicz et al. Sep 1993 A
5244663 Bruttmann et al. Sep 1993 A
5246354 Pardinas Sep 1993 A
5246665 Tyranski et al. Sep 1993 A
5250440 Kelln et al. Oct 1993 A
5252485 Zlobinsky et al. Oct 1993 A
5254312 Staebler et al. Oct 1993 A
5260028 Astle Nov 1993 A
5264182 Sakagami Nov 1993 A
5266272 Griner et al. Nov 1993 A
5270210 Weyrauch et al. Dec 1993 A
5272092 Hamasaki et al. Dec 1993 A
5273715 Bridgham et al. Dec 1993 A
5275299 Konrad et al. Jan 1994 A
5277873 Hsei Jan 1994 A
5279210 Pinkerton Jan 1994 A
5282149 Grandone et al. Jan 1994 A
D344138 Nagata Feb 1994 S
5283079 Wang et al. Feb 1994 A
5286652 James et al. Feb 1994 A
5288466 Burns Feb 1994 A
5290513 Berthold et al. Mar 1994 A
5290708 Ashihara et al. Mar 1994 A
5296191 Hall et al. Mar 1994 A
5296195 Pang et al. Mar 1994 A
5297599 Bucheli Mar 1994 A
5298425 Kuhn et al. Mar 1994 A
5304347 Mann et al. Apr 1994 A
5304787 Wang Apr 1994 A
D347479 Hansen et al. May 1994 S
5309981 Binder May 1994 A
5312730 Piran et al. May 1994 A
5314663 Mimura May 1994 A
5314825 Weyrauch et al. May 1994 A
5315375 Allen May 1994 A
5316245 Ruckwardt May 1994 A
5316726 Babson et al. May 1994 A
5316954 Hupe et al. May 1994 A
5318914 Matte et al. Jun 1994 A
5320809 Dunn et al. Jun 1994 A
5322668 Tomasso Jun 1994 A
5324480 Shumate et al. Jun 1994 A
5332679 Simons et al. Jul 1994 A
5344610 Shaw Sep 1994 A
5346303 Heinonen et al. Sep 1994 A
5348705 Koreyasu et al. Sep 1994 A
5350564 Mazza et al. Sep 1994 A
5351801 Markin et al. Oct 1994 A
5352612 Huber et al. Oct 1994 A
5355304 DeMoranville et al. Oct 1994 A
5363885 McConnell et al. Nov 1994 A
5366062 Markin et al. Nov 1994 A
5366697 Tomasso et al. Nov 1994 A
5370843 Chiodo Dec 1994 A
5371350 Motolese Dec 1994 A
5372782 Karkantis et al. Dec 1994 A
5374395 Robinson et al. Dec 1994 A
5377854 Cusack Jan 1995 A
5378433 Duckett et al. Jan 1995 A
5378881 Adachi Jan 1995 A
5380485 Takahashi et al. Jan 1995 A
5380487 Choperena et al. Jan 1995 A
5380488 Wakatake Jan 1995 A
5384096 Burns Jan 1995 A
5391499 Karkantis et al. Feb 1995 A
5392949 McKenna Feb 1995 A
5393965 Bravman et al. Feb 1995 A
5399846 Pavlidis et al. Mar 1995 A
5401465 Smethers et al. Mar 1995 A
D358660 Swift May 1995 S
5414251 Durbin May 1995 A
5415839 Zaun et al. May 1995 A
D359361 Swift Jun 1995 S
5422075 Saito et al. Jun 1995 A
5424036 Ushikubo Jun 1995 A
5426976 McHardy et al. Jun 1995 A
5427243 Roshdy Jun 1995 A
5428470 Labriola, II Jun 1995 A
5429330 Bond et al. Jul 1995 A
5430957 Eigen et al. Jul 1995 A
5433120 Boyd et al. Jul 1995 A
5434051 Allard et al. Jul 1995 A
5434083 Mitsumaki et al. Jul 1995 A
5437361 Ohmori et al. Aug 1995 A
5437838 DeMoranville et al. Aug 1995 A
5437841 Balmer Aug 1995 A
5439645 Saralegui et al. Aug 1995 A
5439646 Tanimizu et al. Aug 1995 A
5441895 Jakubowicz et al. Aug 1995 A
5442164 Adachi Aug 1995 A
5443790 Coeurveille et al. Aug 1995 A
5443791 Cathcart et al. Aug 1995 A
5445936 Piran et al. Aug 1995 A
5445970 Rohr Aug 1995 A
5445971 Rohr Aug 1995 A
5447687 Lewis et al. Sep 1995 A
5453610 Gibbons Sep 1995 A
5455175 Wittwer et al. Oct 1995 A
5455414 Wang Oct 1995 A
5456360 Griffin Oct 1995 A
5457530 Nagai Oct 1995 A
5458785 Howe et al. Oct 1995 A
5458852 Buechler Oct 1995 A
5462715 Koch et al. Oct 1995 A
5468453 Holt et al. Nov 1995 A
5469749 Shimada et al. Nov 1995 A
5483843 Miller et al. Jan 1996 A
5501841 Lee et al. Mar 1996 A
5503036 Nguyen et al. Apr 1996 A
5507193 Ishihara Apr 1996 A
5519635 Miyake et al. May 1996 A
5543112 Ghead et al. Aug 1996 A
5972295 Hanawa et al. Oct 1999 A
5985672 Kegelman et al. Nov 1999 A
6024204 van Dyke et al. Feb 2000 A
Foreign Referenced Citations (187)
Number Date Country
2058175 Dec 1990 CA
2083424 Nov 1992 CA
51272 Mar 1890 DE
92212 Jun 1897 DE
130053 Apr 1902 DE
338227 Aug 1918 DE
1428777 Mar 1973 DE
2505268 Sep 1975 DE
1798481 Jun 1976 DE
3244508 Jun 1984 DE
3621831 Jan 1988 DE
3934890 Apr 1990 DE
3926462 Feb 1991 DE
0019277 May 1980 EP
0019871 May 1980 EP
0030087 Nov 1980 EP
0038181 Apr 1981 EP
0106536 Sep 1982 EP
0078948 Oct 1982 EP
0080108 Nov 1982 EP
0080109 Nov 1982 EP
0087786 Feb 1983 EP
0097591 Jun 1983 EP
0097591 Jun 1983 EP
0097591 Jun 1983 EP
0100663 Jul 1983 EP
0101192 Jul 1983 EP
0102661 Aug 1983 EP
0106662 Oct 1983 EP
0125995 May 1984 EP
0125995 Jun 1984 EP
0144006 Nov 1984 EP
0148166 Jan 1985 EP
0149565 Jan 1985 EP
0149565 Jan 1985 EP
0149565 Jan 1985 EP
0152964 Feb 1985 EP
0152964 Feb 1985 EP
0167834 Jun 1985 EP
0169434 Jul 1985 EP
0169434 Jul 1985 EP
0169434 Jul 1985 EP
0189280 Jan 1986 EP
0198413 Apr 1986 EP
0209290 Jul 1986 EP
0219695 Sep 1986 EP
0221308 Sep 1986 EP
0239382 Mar 1987 EP
0251087 Jun 1987 EP
0252631 Jun 1987 EP
0252631 Jun 1987 EP
0253519 Jun 1987 EP
0253519 Jun 1987 EP
0273969 Jul 1987 EP
0285654 Oct 1987 EP
0285654 Oct 1987 EP
0269752 Dec 1987 EP
0281390 Mar 1988 EP
0286119 Apr 1988 EP
0549573 Jun 1988 EP
0299659 Jul 1988 EP
0314525 Oct 1988 EP
0353264 Nov 1988 EP
0329183 Feb 1989 EP
0329183 Feb 1989 EP
0316766 May 1989 EP
0346878 Jun 1989 EP
0355801 Aug 1989 EP
0355802 Aug 1989 EP
0355823 Aug 1989 EP
0355823 Aug 1989 EP
0356250 Aug 1989 EP
0356883 Aug 1989 EP
0358948 Aug 1989 EP
0358948 Aug 1989 EP
0396657 Sep 1989 EP
0371265 Oct 1989 EP
0371265 Oct 1989 EP
0417301 Feb 1990 EP
0658762 Feb 1990 EP
0660115 Feb 1990 EP
0409126 Jul 1990 EP
0409606 Jul 1990 EP
0410645 Jul 1990 EP
0410645 Jul 1990 EP
0410645 Jul 1990 EP
0416285 Aug 1990 EP
0435481 Dec 1990 EP
0435481 Dec 1990 EP
0436995 Dec 1990 EP
0438158 Jan 1991 EP
0449321 Mar 1991 EP
0452892 Apr 1991 EP
0365569 May 1991 EP
0467302 Jul 1991 EP
0492499 Dec 1991 EP
0502638 Feb 1992 EP
0502638 Feb 1992 EP
0512368 Apr 1992 EP
0512368 Apr 1992 EP
0523425 Jun 1992 EP
0528708 Jul 1992 EP
0596987 Jul 1992 EP
0597017 Jul 1992 EP
0544578 Nov 1992 EP
0571716 Feb 1993 EP
0572185 May 1993 EP
0572185 May 1993 EP
0572217 May 1993 EP
0596205 Aug 1993 EP
0567892 Nov 1993 EP
0616208 Mar 1994 EP
0637750 Jul 1994 EP
0657382 Jul 1994 EP
0638806 Aug 1994 EP
0638806 Aug 1994 EP
0664501 Aug 1994 EP
0643306 Sep 1994 EP
0645631 Sep 1994 EP
0653720 Nov 1994 EP
0661535 Dec 1994 EP
0670483 Feb 1995 EP
0682258 Feb 1995 EP
0672906 Mar 1995 EP
0692308 Jul 1995 EP
0712000 Sep 1995 EP
0712000 Sep 1995 EP
0712000 May 1996 EP
0712000 Jun 1996 EP
1573224 Apr 1968 FR
1573224 Apr 1969 FR
2144110 Feb 1973 FR
2309869 Apr 1976 FR
2523320 Mar 1983 FR
2655426 Dec 1990 FR
1-23637 Aug 1964 GB
1180957 Dec 1967 GB
1473042 May 1977 GB
1566098 Apr 1980 GB
1592297 Jul 1981 GB
1592299 Jul 1981 GB
2199407 Jul 1988 GB
2202814 Oct 1988 GB
2228730 Sep 1990 GB
2239093 Jun 1991 GB
1322728 Nov 1969 JP
60-188849 Sep 1985 JP
62-49070 Mar 1987 JP
62-165057 Jul 1987 JP
62-194464 Aug 1987 JP
2-210266 Aug 1990 JP
4047266 Feb 1992 JP
WO 8002280 Oct 1980 WO
WO 8600139 Jan 1986 WO
WO 8605518 Sep 1986 WO
WO 8703966 Jul 1987 WO
WO 8707727 Dec 1987 WO
WO 8802866 Apr 1988 WO
WO 8904373 May 1989 WO
WO 9107662 Nov 1989 WO
WO 9000252 Jan 1990 WO
WP 9001168 Feb 1990 WO
WO 9005903 May 1990 WO
WO 9011511 Oct 1990 WO
WO 9005411 May 1991 WO
WO 9107662 May 1991 WO
WO 9113335 Sep 1991 WO
WO 9115768 Oct 1991 WO
WO 9205448 Apr 1992 WO
WO9212255 Jul 1992 WO
WO 9216841 Oct 1992 WO
WO 9216844 Oct 1992 WO
WO 9220449 Nov 1992 WO
WO 9222201 Dec 1992 WO
WO 8301308 Jan 1993 WO
WO 9301308 Jan 1993 WO
WO 9302364 Feb 1993 WO
WO 9303383 Feb 1993 WO
WO 9312430 Jun 1993 WO
WO 9312431 Jun 1993 WO
WO 9316801 Sep 1993 WO
WO 9322686 Nov 1993 WO
WO 9404929 Mar 1994 WO
WO 9419451 Sep 1994 WO
WO 9500829 Jan 1995 WO
WO 9503548 Feb 1995 WO
9625712 Aug 1996 WO
Non-Patent Literature Citations (87)
Entry
Luninescent Labels for Immunoassay From Concept to Practice; F. McCapra et al., Journal of Bioluminescence and Chemiliminescence vol. 4 51-58 1989.
J. Guesdon, et al Magnetic Solid Phase Enxyme Immunoassay; Immunochemistry 1977, vol. 14 443-447.
Yolken; Enzyme Immunoassays for the Detection of Infectious Antigens in Body Fluids: Current Limitations and Future Prospects; Reviews of Infectious Diseases vol. 4, No. 1 Jan.-Feb. 1982.
Hirschbein, et al; Magnetic separations in chemistry and biochemistry; Chemtech Mar. 1982.
Oellerich; Enzyme-Immunoassay: A Review J. Clin Chem Clin Biochem vol. 22, 1984 pp895-904.
Guesdon, et al.;Magnetic enzyme immunoassay for measuring human IgE; J. Allergy Clin Immunol Jan. 1978; vol. 61, No. 1, 23-27.
Kamel, et al; Magnetizable Solid-Phase Fluoroimmunoassay of Phenytoin in Disposable Test Tubes; Clin chem 26/9/1281-1284 (1980).
Klibanov; Immobilized Enzymes and Cells as Practical Catalysts; Science vol. 219.
Mosbach, et al; Magnetic ferrofluids for preparation of magnetic polymers and their application in affinity chromatography; Nature vol. 270 Nov. 17, 1977.
Dawes, et al.; Radioimmunoassay of Digoxin Employing Charcoal Entrapped in Magnetic Polyacrylamide Particles; Clinica Chimica Acta 86 1978; 353-356.
Nye,et al., Solide Phase, Magnetic Particle Radioimmunoassay; Clinica Chimica Acta 69(1976) 387-396.
Hersh,et al; Magnetic Solid Phase Radioimmunoassay; Clinica chimica Acta, 63 1975 69-72.
Pourfarzaneh, et al., Cortisol Directly Determined in Serum by Fluoroimmunoassay with Magnetizable Solid Phase; Clin Chem 26/6 730-733.
Kamel, et al., Nove 125I-Labeled Nortriptyline Derivatives and Their Use in Liquid Pahse or Magnetizable Solid Pahse Second-Antibody Radioimmunoassays; Clin Chem 25/12, 1997-2002 (1979).
Ithakissioset al., Use of Protein Containing Magnetic Microparticles in Radioassays; Clin chem 23/11; 2072-1079 (1977).
Robinson; The Properties of Magnetic Supports in Relation to Immobilized Enzyme Reactors; Biotech and Bioeng. vol. XV 1973.
Carter; Preparation of Ligand Free Human Serum for Radioimmunoassay by Adsorption on Activated Charcoal; Clin Chem 24/2, 362-364(1978).
Jacobs; Separation Methods in Immunoassays; The Ligand Quarterly vol. 4, No. 4, 1981.
Rembaum et al., Synthesis and Reactionsof Hydrophilic Functional Microspheres; J. Macromaol Sci Chem A13(5) 603-632 (1979).
Pourfarzaneh, et al, Production and Use of Magnetizable Particles in Immunoassay, The Ligand Quarterly, vol. 5, No. 1, 1982.
Kaiser, et al., Magnetic Properties of Stable Dispersions of subdomain Magnetite Particles; Journal of Applied Physics; vol. 41, No. 3, Mar. 1970.
Halling et al., Magnetic supports for immobilized enzymes and bioaffinity adsorbents; Enzyme Microb Technol. 1980 vol. 2, Jan.
Allman, et al., Fluoroimmunoassay of Progesterone in Human Serum of Plasma; Clin Chem 27/7 1176-1179-(1981).
Radioimmunoassay and Related Procedures in Medicine 1982.
Klingler, et al., Immunoassay of unconjugated estriol in serum of pregnant women monitored by chemiluminescence; Steroids, vol. 42, No. 2, Aug. 1983.
Wisdom; Enxyme Immunoassay; Clin Chem 22/8/1243-1255 (1976).
Scholmerich, et al., Bioluminescence and Chemiluminescence; New Perspectives.
Thorpe et al., [29]Enhanced Chemiluminescent Reactions Catalyzed by Horseradish Peroxidase; Method in Enzymology vol. 133.
Margel et al., Polyglutaraldehyde: A new reagent for coupling proteins to microspheres and for labeling cell surface receptors . . . ; Jounal of Immunologica Methods 28(1979) 341-353.
Margel; Polyaldehyde Microspheres as Probes for Cell Membranes; Ind. Eng. Chem. Prod. Res. Dev. 1982, 21, 343-348.
Sovetskaia Meditsina No Translation.
Margel, et al., Polyacrolein Microspheres as a New Tool in Cell Biology, J. Cell Sci. 56, 157-175 (1982).
Margel, et al., Cell Fractionation with Affinity Ligands Conjugated to Agarose-Polyacrolein Microsphere Beads; J. Cell Sci. 62, 149-159(1983).
Kreuter; Evaluation of Nanoparticles as Drug-Delivery Sysntems I: Preparation Methods. Pharm Acta Helv. 58 No. 7, 1983.
Margel, et al., Chelation of Mercury by Polymercaptal Microspheres: new Potential Antidote for Mercury Poisoning; Joun of Pharm. Sciences; vol. 71. No. 9, Sep. 1982.
Basch, et al., Cell Separation Using Positive Immunoselective Techniques, Journ. of Immunol. Methods, 56(1983) 269-280.
Kaplan,et al., The Selective Detection of Cell Surface Determinants by means of Antibodies and Acetylated Avidin Attached tooHighly Fluorescent Polymer Microspheres; Biochem and Biophysic Acta 728(1983)112-120.
Margel, et al., Novel Effective Immunoadsorbents Based on Agarose-Polyaldehyde Microsphere Beads: Synthesis and Affinity Chromatography, Analytical Biochem. 128 342-350(1983).
Marcus, et al., A New Immunoadsorbent for Hemoperfusion: Agarose-Polyacrolein Microsheres Beads; Biomat Med. Dev., Art. Org. 10(3) 157-171 (1982).
Merivuori, et al., Cell Labelling and separation with polyglutaraldehyde microspheres; Exp Cell Res 130 (1980).
Kempner,et al., Electrophoretic cell sepatation using polyacrolein microspheres, Electrophosesis 1982, 3, 109-113.
Kumakura et al.,; Polymeric Microspheres for Immunoresearch; Immunological communications 13(2), 119-125(1984).
Morimoto et al., Dispersion State of Protein stabilized Magnetic Emulsions; Chem Pharm Bull 30(8) 3024-3027(1982).
Boland et al., The Ciba Corning ACS:180 Benchtop Immunoassay Analyzer; Clin Chem 36/9, 1598-1602 (1990).
ACS:180 Automated Chemiluninescence System.
Rembaum et al., Immunomicrospheres: Reagents for Cell Labeling and Separation, Science vol. 208. Apr. 25, 1980.
Tokes et al., Synthesis of adriamycin coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity; Proc Natl. Acad Sci. USA vol. 79: 2026-2030 Mar. 1982.
Margel et al., Synthesis and Characterization of Poly(glutaraldehyde). A Potential Reagent for Protein Immobilization and Cell Separation; Macromolucule vol. 13, No. 1, Jan. Feb. 1980.
Margel; Characterization and Chemistry of Polyaldehyde Microshpheres; Journ of Polymer Science vol. 22, 3521-3522(1984).
Marcus et al., Extracorporeal removal of specific antibodies by hemoperfusion through the immunosorbent agarase-polyacrolein micrsphere beads: Remaoval of Anti-bovine serum albumin in animals; Journ of Viomed Materials Research vol. 18 1153-1167(1984).
Margel; Agarose polyacrolein microsphere beads;Febs Letter; vol. 145 No. 2; Aug. 1982.
Margel et al., Novel Effective Immunoadsorbents Based on Agarose-Polyaldehyde Microshere Beads: Synthesis and Affinity Chromatography; Analytical Biochem 128(342-350(1983).
Margel et al., Polyacrolein Microspheres as a new tool in cell biology; J. Cell Sci 56, 157-175(1982).
Marel et al., A novel synthesis of polyacrolein microspheres and their application for cell labeling and cell separation; Immuno Communications 10(7), 567-575(1981).
Hage et al., High performance immunoaffinity chromatography and Chemiluminscent Detection in the Automation of a Parthyroid Hormone Sandwich Immunoassay; Anal. Chem 1991, 63, 586-595.
Bronstein et al., Instrumentation for luminescent assays; ACL: 33.
Campbell, Chemiluminescence Principles and Applications in Biology and Medicine.
The Ideal chemiluminometer. Sec. 2.4.
Chemiluminescence immunoassay Sec. 8.2.
O'Brien et al., The magic lite system and acridinium esterbased immunoassays; Immunoassay Automation: A practical guide.
Dudley; Chemiluminescence Immunoassay: An Altermantive to RIA; Laboratory Medicine vol. 21, No. 4, Apr. 1990.
Dyke; Luminescence Immunoassay and Molecular Applications.
Luminescence Immunopassay and Molecular Applications; pp. 69-75, 149-156.
Woodhead et al., Magic Lite Design and Development, Journ of Bioluminescence vol. 4, 611-614 (1989).
Express. New Intellegent random access cheimistry analysis Circle No. 578.
Shamberger et al., Evaluation of bichromatic random access analyzer; Analyzer Oct. 1989, 22.
The Lancet Jan. 14, 1984. vol. 1 1984.
550 EXPRESS Shemistry Analyzer.
T3 Uptake [1251] Radioassay MAGIC Ciba Corning.
Quality Value. Customer Satisfaction Ciba Corning Diagnostics Corp.
Corning Magic Lite II.
ACS-180.
Kamel et al., Magnetizable Solid-Phase Fluoroimmunoassay of Phenytoin in Disposable Test Tubes; Clin Chem vol. 26, No. 9. 1980.
Berry et al., A Laboratory and Clinical Evaluation of an Immunochemiluminometric Assay of Thyrotropin in Serum; Clin Chem. vol. 34. No. 10, 1988.
Weeks et al., Chemiluminescence immunoassay: an overview; Clin Science 1986 70,403-408.
Weeks et al., Acridinium Esters as High-Specific-Activity Labels in Immunoassay; Clin Chem 29/8, 1474-1479(1983).
Shridi et al., A direct fluoroimmunoassay for conjugated chenodeoxycholic acid using antibody coupling to magnetisable particles; Ann Clin Biochem 1980; 17:188-191.
Sidki et al., Direct determination of primidone in serum of plasma by a magnetisable solid-phase fluoroimmunoassay; Ann Clin Biochem 1983:20: 227-232.
Abdulla et al., Development of a Magnetisable solid-phase fluoroimmunoassay for primaquine and carboxyprimaquine; Southeast Asian J. Trop Med. Pub Hlth. vol. 20, No. 3, 1989.
Ciba Corning Laboratory Diagnostic Reagents and Systems packet.
Patent Abstracts of Japan vol. 16 Num 225(p1360).
Symbol: A New Communications Medium fo the Information Age.
European Search Report ep 92 30 1483.
The Future of Bar Coding.
Symbol Technologies: The Bar Code Data Capture Company.
Symbol Just What the Doctors Ordered: Met Path Boosts Qualigy, Beats the Competition with PDF417.
Symbol: A PDF417 Primer: A guide to understanding second generation bar codes and portable data files.